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The genome-wide roles of the lung lineage transcription factor NKX2-1 in the 
regulation of opposing cell fates in vivo 
Danielle R. Little, B.S.* 
Advisory Professor: Jichao Chen, Ph.D. 
Lineage transcription factors mark, promote, and maintain multiple distinct cell types originating 
from a common progenitor. Despite their essential role, how such factors function and bind genome 
wide to orchestrate the epigenetic changes necessary to form and maintain these identities in vivo is 
unclear. One lineage transcription factor NK Homeobox 2-1 (NKX2-1) is expressed throughout the 
lung epithelium during development and was thought to be lost in the extraordinarily thin cell type 
required for gas exchange– the alveolar type 1 (AT1) cell. Complementing precise genetic 
knockouts with cell type-specific ChIP-seq, ATAC-seq, and scRNA-seq, our study shows that AT1 
and AT2 cells both express and require Nkx2-1 for their development and maintenance through 
NKX2-1 mediated regulation of cell type-specific genes. Furthermore, NKX2-1 is guided by cell 
type-specific transcription factors, binding to regulatory elements unique to AT1 or AT2 cells. In the 
absence of AT1 cell type-specific transcription cofactors in AT1 cells, NKX2-1 reverts to AT2 cell 
type-specific binding resulting in an AT1 to AT2 cell fate conversion. This remarkable cellular 
plasticity was further exemplified by loss of Nkx2-1, whereupon both AT1 and AT2 cells first lose 
chromatin accessibility at their respective cell type-specific and lineage Nkx2-1 binding sites and 
gain chromatin accessibility at NKX2-1 sites specific to the alternate cell fate within the alveolar 
epithelium, followed by a final shift to gastrointestinal lineage identity. These data suggest that in 
vivo, lineage transcription factors positively establish and maintain lineage and cell type identity 
with the aid of cell type-specific transcription factors, while repressing alternative cellular identities. 
This study not only demonstrates how a lineage transcription factor regulates the development, and 
maintenance of distinct cell epigenomes, but also establishes an experimental paradigm to further 
investigate lineage transcription factors in vivo.  
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Chapter 1: Introduction 
 
1.1 Lineage transcription factors 
With the advent of single-cell technology, the complexity of mammalian tissue is being 
unraveled with each discovery of new cell types. Despite the growing number and abundance of 
cell types, the DNA blueprint originating each distinct cell type is the same, with only a subset 
of DNA regulatory elements with chromatin accessible for activation of the respective cell type-
specific transcriptional programs. Such programs arise during developmental patterning, where 
transcription factors are hierarchically deployed to specify cell fates. The unique combinations 
of these transcription factors extend the diversity of cell fates achieved across spatiotemporal 
contexts. One subset of transcription factors, lineage transcription factors, are expressed 
uniformly throughout the specification, development, and maintenance of multiple distinct cell 
fates descending from a common progenitor such as the pancreatic endocrine cell types 
expressing ISL1 or epithelial cells in the lung marked by expression of NK Homeobox 2-1 
(NKX2-1) (Ediger, Du et al., 2014, Minoo, Hamdan et al., 1995).  While they echo the function 
of traditional master regulators that specify cellular differentiation of a tissue lineage such as 
Myod1 in the muscle (Tapscott, 2005), lineage transcription factors continue to actively 
maintain cellular identity, defined by the functional transcriptional profile of the cell type, 
within the tissue lineage after cellular specification.  
Although many transcription factors are expressed homogenously throughout a tissue 
lineage, as with NKX2-1, FOXA1/2, and FOXP1/4 in the lung epithelium alone (Minoo et al., 
1995, Shu, Lu et al., 2007, Wan, Dingle et al., 2005), dissection of their roles in each individual 
cell type is necessary to discern whether their functions in transcriptional regulation are distinct 
or shared between cell types. Thus, there are few instances describing the role of lineage 
transcription factors in establishing individual cellular identities. While key principals 
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underlying differential function of transcription factors between cellular contexts may be 
applicable to lineage transcription factors, many of such studies are limited to in vitro work. The 
reason for the use of in vitro research in this context is largely due to the need for an abundance 
of cells, genetic manipulations, and profiling of the epigenome, defined as a collection of 
modifications to DNA that influence transcriptional activity without altering the DNA sequence, 
required across cell types and temporal contexts. In truly characterizing the function of lineage 
transcription factors in vivo, we not only contribute to our understanding of how cellular 
identity is formed and maintained across a tissue lineage in vivo, but also support the previous 
studies laying the ground work for our understanding of transcriptional regulation in cellular 
identity.   
 
1.2 Transcription factors in cellular identity, differentiation, and plasticity 
Cell types are defined in multiple manners, based on physiological function, 
morphological properties, developmental history, and with the advent of next generation 
sequencing, collections of features not pronounced on the cell surface such as transcriptomic or 
epigenetic signatures. While we continue to find more ways to characterize cellular identity, 
how each characteristic interplays with one another to orchestrate cell fate remains unclear. To 
complicate cellular identity further, it is maintained through continued reinforcement and active 
repression of alternative cell fates. Both aspects of cellular identity rely upon transcription 
factors to activate and maintain cell type-specific transcriptional programs. This is achieved 
through transcription factor binding to specific DNA motifs at both promoters adjacent to the 
transcription start site and enhancers distal to respective target genes and thus facilitates or 
impedes the recruitment of transcriptional machinery, chromatin remodelers, or histone and 
DNA modifiers. Furthermore, transcription factors’ DNA binding preferences may change with 
different co-transcription factors. Together, this variety of binding patterns and functions enable 
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a single transcription factor to regulate cellular identity through multiple mechanisms. Adding to 
the complexity of transcription factor function in this context, some transcription factors carry 
out redundant roles or control a subset of genes related to cell identity, while others are essential 
for specific stages in establishing identity or are required for both specification and 
maintenance.  
Deletion or overexpression of selector transcription factors that control identity in 
distinct cell types can lead to a conversion of cell fate. The resulting fate upon loss of a selector 
transcription factor is typically associated with the developmental history of the original cell 
type (Arlotta & Hobert, 2015). In the murine brain, deletion of terminal cell fate transcription 
factors such as Helt led to a shift cell fate of neurons in the mesencephalon from GABAergic to 
glutamatergic– another neuronal identity within that region of the brain arising from the same 
progenitors (Nakatani, Minaki et al., 2007). Similarly, deletion of the transcription factor Otx2 
in neural progenitors of the midbrain drives a switch to a cell fate associated with the 
cerebellum in the hindbrain (Vernay, Koch et al., 2005). While forebrain, midbrain, and 
hindbrain share developmental origins from the neural ectoderm, Otx2 expression is limited to 
progenitors of the forebrain and midbrain which could explain this developmental conversion 
(Simeone, 2000). Lineage switching has also been observed in mature cells. For example, 
epithelial cells of the lung start to express gastrointestinal epithelial genes upon loss of the lung 
lineage selector Nkx2-1 (Tata, Chow et al., 2018). In this context, transcription factors shared 
across organs derived from the foregut endoderm, FOXA1/2, shift binding to gastrointestinal 
genes to drive this conversion (Camolotto, Pattabiraman et al., 2018, Snyder, Watanabe et al., 
2013). Between each example, cells are limited to conversion to a cell type with a shared 
developmental history. However, explanations for such cellular conversions vary. In the lung 
epithelium, maintained transcription factors FOXA1/2 shift to binding associated with another 
endodermal fate (Snyder et al., 2013), whereas Otx2 and Helt are thought to inhibit the 
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expression of the alternative cell fate transcription factors (Nakatani et al., 2007, Vernay et al., 
2005). Together, this suggests that not only do transcription factors maintain stable unique 
cellular identities, but at the same time repress varying levels of alternative cellular identity. 
These alternative cellular identities are often associated with cell types of a common 
developmental history, suggesting that the path of least resistance is through either shared 
expression of common transcription factors or less epigenetic repression at relevant regulatory 
elements. 
 Transcription factors mediating cellular differentiation are often subject to regulation via 
signal transduction pathways. Intercellular signaling or changes in the physical environment 
such as mechanical stretch lead to activation of the signaling pathway and translocation of a co-
factor into the nucleus to initiate transcription factor binding (Adam, Yang et al., 2018, 
Trompouki, Bowman et al., 2011). While this process is commonly associated with cellular 
differentiation, cells continually receive inputs from their environment. When removed from 
their niche and cultured in vitro, murine hair follicle stem cells undergo epigenome remodeling, 
resulting in suppression of hair follicle stem cell transcription factors despite largely 
maintaining their cellular identity (Adam & Fuchs, 2016). This expression is re-established 
upon engraftment, suggesting that the microenvironment is necessary to maintain these essential 
regulatory elements (Adam & Fuchs, 2016, Gosselin, Link et al., 2014, Lavin, Winter et al., 
2014). Changes in cellular plasticity, the ability of a cell to take on a transcriptomic profile of 
different cellular identities, have also been observed when culturing cells in vitro. Secretory 
cells from the airways of the murine lung undergo de-differentiation when cultured in vitro and 
express markers associated with stem cell potential (Tata, Mou et al., 2013). Furthermore, the 
addition of the resident stem cells of lung epithelium, basal cells, to secretory cell in vitro cell 
cultures restrained such dedifferentiation (Tata et al., 2013). The converse has also been 
observed in vivo, where ablation of stem cells within the niches of the hair follicle, lung 
 5 
epithelium, or intestinal crypts yields an increased stem cell capacity of nearby cell types, 
whether they were originally quiescent under steady state or not (Ge & Fuchs, 2018). Such 
findings exemplify that the epigenome, cellular identity, and plasticity are all responsive to the 
microenvironment and, in addition to intrinsic differences between in vitro mRNA and protein 
expression profiles from their in vivo tissue counterparts, imparts the need for in vivo cell type-
specific analyses.   
 
1.3 Lung Development 
1.3.1 Cell types of the lung 
 Air inhaled from the environment diffuses across the epithelial lining of the vertebrate 
lung into the blood stream in a process known as gas exchange, whereupon oxygen enters the 
blood stream and carbon dioxide leaves the blood stream, passing through the epithelium to be 
exhaled. This unique interface with the external environment relies upon the epithelial lining of 
the lung and its close connection with the endothelial capillaries in what are known as alveoli – 
the air sacks populating the distal tips of the lung. These extraordinary structures are a 
continuum of folded epithelium budding off from alveolar ducts, which are alveolar cell-lined 
extensions of the airways. This alveolar region is comprised of two distinct cell types, the ultra-
thin and expansive alveolar type (AT) 1 cell and the cuboidal AT2 cell. While only a minor 
percentage of the cells within the lung epithelium, AT1 cells cover 95% of the gas exchange 
surface and are on average 0.1 µm thick (Weibel, 1971, Yang, Hernandez et al., 2016) (Figure 1 
A and B). In contrast, the AT2 cell provides surfactants that serve to reduce the tension across 
this thin surface and contribute to host defense against pathogens (Beers & Moodley, 2017) 
(Figure 1 A and B). In addition to such functions, the AT2 cell is also known to participate in 
homeostatic turnover and regeneration in the lung upon injury, serving as a facultative stem cell 
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reservoir to replenish both AT1 and AT2 cells (Barkauskas, Cronce et al., 2013, Beers & 
Moodley, 2017, Desai, Brownfield et al., 2014).   
Figure 1:  
 
Fig. 1. Cell types of the alveolar epithelium 
(A) Schematics of AT1 cells (traced from an immunostained P3 lung) with en face imaging of 
P3 alveolar region stained for the epithelial junction protein E-cadherin (scale bar 10 µm). (B) 
Conventional sectional view captures part of an AT1 cell as demonstrated with transmission 
electron microscopy, the basement membrane of the one AT1 cell and two individual AT2 cells 
are traced with white dashed lines.  
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 In addition to the AT1 and AT2 cells of the alveolar region, the epithelial lineage is also 
comprised of the epithelial cell types lining the upper and lower airways including the secretory, 
ciliated, goblet, neuroendocrine, basal cells, and ionocytes that serve as the first line of defense 
against inhaled pathogens (Montoro, Haber et al., 2018, Rock & Hogan, 2011). Both secretory 
and goblet cells secrete mucins to help trap pathogens, while ciliated cells sweep this mucus to 
the top of the trachea to be expelled (Rock & Hogan, 2011). More recent evidence suggest that 
neuroendocrine cells play a role in this process by sensing allergens and alerting immune cells 
and that ionocytes maintain mucous physiology (Kobayashi & Tata, 2018, Montoro et al., 
2018). Basal cells, as their name suggests, are present underneath the pseudostratified airway 
epithelium where they replenish ciliated, secretory, neuroendocrine cells, and ionocytes under 
homeostatic conditions (Hogan, Barkauskas et al., 2014, Montoro et al., 2018, Zaragosi, Deprez 
et al., 2020). Despite the unique functions of each of these distinct cell types within the airway 
and alveolar epithelium, they collectively descend from one common lineage of progenitors 
specified within lung bud formation from the foregut endoderm (Hogan et al., 2014, Rankin & 
Zorn, 2014). 
  
1.3.2 Early lung development 
 After specification of the endoderm, ectoderm, and mesoderm during gastrulation, the 
endoderm elongates into three pre-patterned regions anterior to posterior: the foregut, midgut, 
and hindgut (Kim & Shivdasani, 2016, Zorn & Wells, 2009). The foregut gives rise to the 
esophagus, trachea, lungs, liver, pancreas, and stomach, while the midgut and hindgut originate 
the small intestine and colon respectively (Kim & Shivdasani, 2016, Zorn & Wells, 2009). 
Specification of lung progenitors is observed at embryonic day (E) 9 in murine lungs and at 4 
weeks of human gestation (Schittny, 2017). After specification, the lung undergoes 5 stages of 
lung development: embryonic, pseudoglandular, canalicular, saccular, and alveolar. The 
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embryonic stage depicts the lung’s specification from the foregut (mice: E9-E12, humans: 4-7 
weeks) and is then followed by the pseudoglandular stage characterized by initial branching 
(mice: E12-E16.5, humans: 5-17 weeks). Then within the canalicular stage, branching 
morphogenesis is completed and alveolar ducts are formed (mice: E16.5-E17.5, human: 16-26 
weeks) followed by the formation of alveolar sacs at the distal tips during the saccular stage 
(mice: E17.5-P4, human: 24-38 weeks). Alveologenesis, the final stage of lung development, is 
characterized by the subdividing of alveolar sacs into alveoli (mice: postnatal day (P) 4-P36, 
human: 36 weeks-21 years) (Schittny, 2017).  
 The previously described stages of lung development are largely defined by 
morphological characteristics, which have limited application due to the asynchrony of cellular 
differentiation during lung organogenesis. The cells left behind from continual branching of the 
distal tips are subsequently differentiated, resulting in cells closer to the descending airways 
being more mature and differentiated while the distal tip is still predominantly composed of 
undifferentiated progenitors (Alanis, Chang et al., 2014). For this reason, it is necessary to re-
contextualize the previously mentioned stages with gene expression on the cellular level to 
characterize development spatiotemporally. Initiation of formation of the lung bud is through 
WNT signaling originating from the anterior mesoderm, which activates NKX2-1 expression 
and BMP4 signaling from newly specified epithelial cells (Goss & Morrisey, 2010). In turn, this 
suppresses esophageal SOX2 expression in the lung bud, allowing for a physical separation 
between the following tracheal and esophageal tissue (Que, Okubo et al., 2007). Subsequent 
NKX2-1 positive progenitors divide, expanding the progenitor pool while sending/receiving 
intercellular signals to/from the mesenchymal cells enveloping the lung bud. Selective feedback 
and inhibitory signals from the epithelium result in the initiation of branching, whereupon 
progenitors at the distal tips express SOX9 and ID2 (Herriges & Morrisey, 2014). Lineage 
tracing experiments with Sox9CreER and Id2CreER indicate that most if not all airway cells left 
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behind during branching morphogenesis arise from distal tip progenitors (Alanis et al., 2014, 
Rawlins, Clark et al., 2009). These residual cells in the airway lose expression of SOX9 and 
ID2, instead expressing SOX2, a defining transcription factor of all airway cell types (Alanis et 
al., 2014). SOX2 progenitors then differentiate into neuroendocrine, secretory, and ciliated cells 
based on levels of NOTCH signaling (Herriges & Morrisey, 2014). After E13.5, SOX9 
progenitors, previously capable of producing both airway and alveolar cell types, are restricted 
to generating cells of alveolar fate (Alanis et al., 2014). For production of AT1 and AT2 cells at 
E16.5, SOX9 progenitors require expression of epithelial transcription factors Sox9, Foxa1/2, 
and Foxp1/2/4 to differentiate (Rockich, Hrycaj et al., 2013, Shu et al., 2007, Wan et al., 2005). 
 
1.3.3 AT1 cell development 
 The expression of AT1 cell-specific genes is first observed at E16.5 during the 
canalicular stage when fetal breathing, where embryos inhale embryonic fluid into the distal 
airways, first occurs (Kitterman, 1996, Moessinger, Harding et al., 1990). As previously 
mentioned, the first cells to develop into AT1 cells are those closest to the terminal bronchi, 
lining alveolar ducts (Alanis et al., 2014, Yang et al., 2016). The last wave of cells to 
differentiate into AT1 or AT2 cells is observed within the distal tips at E18.5 and P0 (Yang et 
al., 2016). AT1 cells undergoing differentiation first flatten through reorganization of their 
adherens junctions. After flattening, at P5 AT1 cells undergo folding and expand more than 10-
fold, reaching a maximum of ~12,000 µm2 in surface area by P30 (Yang et al., 2016). AT1 cells 
are thought to be embryonically specified from SOX9 progenitors as the AT1 cell number only 
doubles postnatally and remains stable after the first week, while AT2 cell number nearly 
increases 6-fold from P0 to P54 (Yang et al., 2016). After specification of AT1 cell identity, 
AT1 cells do not proliferate, as opposed to AT2 cells that express the proliferative marker KI67 
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with incremental reduction to low homeostatic levels over time (Barkauskas et al., 2013, 
Liebler, Marconett et al., 2016).  
 
1.3.4 SOX9 progenitors and AT2 cells 
  SOX9 progenitors share expression of AT2 cell genes in addition to their own 
transcriptional program, which has led to two models for differentiation of progenitors into AT1 
and AT2 cells. The first model depicts AT2 cells arising from progenitors and subsequently 
differentiating into AT1 cells (Adamson & Bowden, 1975). The second model depicts SOX9 
progenitors as bipotential – capable of making both AT1 and AT2 cells (Desai et al., 2014). 
Supporting this second model, differentiating AT2 cells possess lamellar bodies not observed in 
SOX9 progenitors, and partially flattened early AT1 cells also do not contain such lamellar 
bodies (Beers & Moodley, 2017). Furthermore, lineage tracing of newly-differentiated AT2 
cells with a late AT2 Cre driver LysMCre only labeled AT2 cells and myeloid cells when 
quantified at P14 (Desai et al., 2014).   
Differentiation of SOX9 progenitors is thought to be inhibited by the transcription factor 
SIX1, a known regulator of cell cycle genes and apoptosis (El-Hashash, Al Alam et al., 2011, 
Lu, Reddy et al., 2013). Six1 null lungs express high levels of AT2 genes, and reduced 
expression progenitor genes compared to control lungs at E14.5 (El-Hashash et al., 2011, Lu et 
al., 2013). This suggests that a subset of transcription factors in the SOX9 progenitors prevent 
epithelial differentiation and must be repressed in order for normal lung development to occur. 
Dissecting the underlying transcriptional program positively regulating differentiation of AT2 
cells from progenitors has been met with difficulty as transcription factor families that have 
specific gene expression in AT2 cells such as AP-1, ATF, ELFs, CEBP, and ETVs often also 
have expression in SOX9 progenitors or possible roles in branching (Herriges, Yi et al., 2012, 
Ramana, 2019). Thus, many such mutants exhibit branching defects and loss of both AT1 and 
 11 
AT2 cell markers, making it difficult to determine if factors cell-autonomously regulate AT2 
cell differentiation in the embryonic lung. However, it is known that Ctnnb1 is required to 
maintain AT2 identity during development (Frank, Peng et al., 2016). Deletion of this co-
transcription factor of canonical WNT signaling leads to AT2-AT1 differentiation in the 
neonatal lung (Frank et al., 2016). This requirement of Ctnnb1 for maintenance of AT2 identity 
and suppression of AT1 cell identity is recapitulated in the mature lung (Nabhan, Brownfield et 
al., 2018). Unlike AT1 cells, AT2 cells appear to morphologically develop with haste and adopt 
a transcriptional program close to their mature counterparts relatively early, which suggests that 
AT2 cells may possess different developmental kinetics than AT1 cells.  
  
 
1.4 Lung lineage transcription factor NKX2-1 
1.4.1. NKX2-1 in development  
 NKX2-1 is expressed in the lung bud and is typically used to mark epithelial progenitors 
at E9.5 in mice (Rankin & Zorn, 2014). However, Nkx2-1 mutant lungs continue to develop 
until E12.5 to E15.5 with the formation of initial bronchi that bifurcate from a trachea 
abnormally fused to the esophagus (Minoo et al., 1995, Minoo, Li et al., 1997). Distal tips of 
these bronchi were dilated and comprised of cells with cilia on the apical surface, lacking 
expression of surfactants (Minoo et al., 1995, Minoo et al., 1997). Thus, while Nkx2-1 mutants 
still specify the lung epithelium, branching morphogenesis and differentiation of AT2 cells was 
disrupted (Minoo et al., 1995, Minoo et al., 1997). However, mice heterozygous for Nkx2-1 
deletion do not exhibit a developmental lung phenotype. This is due to increased expression of 
NKX2-1 from the remaining viable locus spurred by the long non-coding RNA NANCI 
(Herriges, Tischfield et al., 2017). When mice were heterozygous for deletion of both Nkx2-1 
and NANCI, Nkx2-1 expression was decreased and thus a reduction in expression of epithelial 
markers was observed postnatally. Interestingly, unlike the previous homozygous deletion of 
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Nkx2-1, mice heterozygous for both Nkx2-1 and NANCI exhibited increased levels of 
proliferation. While this was the case, 4-week-old double heterozygous mice had similar levels 
of Nkx2-1 compared to single Nkx2-1 heterozygous mice, and exhibited levels of wildtype 
epithelial genes expression with normal lung morphology (Herriges et al., 2017).  
 
1.4.2 NKX2-1 related disorders 
NKX2-1 is also expressed in the brain and thyroid in addition to the lung epithelium. As 
such, NKX2-1 mutations are related to disorders across the brain, thyroid, and lung classified 
together as a rare genetic disorder known as brain-lung-thyroid syndrome (Patel & Jankovic, 
1993). Out of the individuals diagnosed with brain-lung-thyroid syndrome, roughly 50% of 
individuals have pulmonary involvement with varying levels of severity (Gras, Jonard et al., 
2012). Patients with severe pulmonary manifestations often have neonatal respiratory distress 
syndrome, while other individuals were at risk for recurrent pulmonary infections and 
developing chronic interstitial lung disease due to a decrease in surfactant production by AT2 
cells (Carre, Szinnai et al., 2009, Inzelberg, Weinberger et al., 2011, Peca, Petrini et al., 2011). 
In individuals with brain-lung-thyroid syndrome, other lung manifestations such as emphysema 
and hyperplasia of alveolar epithelial cells have also been reported (Moya, Zaballos et al., 2018, 
Willemsen, Breedveld et al., 2005). In concordance with alveolar hyperplasia, individuals with 
brain-lung-thyroid syndrome have an increased risk for lung cancer (Willemsen et al., 2005).  
 
1.4.3 NKX2-1 in lung cancer 
In lung adenocarcinoma, one of the two non-small cell lung cancer subtypes, NKX2-1 is 
considered both a lineage-specific oncogene and a lineage-specific tumor suppressor 
(Yamaguchi, Hosono et al., 2013). While lost in roughly 20-30% of lung adenocarcinoma cases, 
in the remaining 70-80%, NKX2-1 is highly expressed and even amplified in 10% of cases 
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(Kwei, Kim et al., 2008, Tanaka, Yanagisawa et al., 2007, Yatabe, Mitsudomi et al., 2002). 
When highly expressed, NKX2-1 is thought to function through EGFR signaling to promote 
pro-survival signaling in cancer cells (Yamaguchi, Yanagisawa et al., 2012). When NKX2-1 
expression is lost in patients with lung adenocarcinoma, epithelial cells undergo a mucinous 
transformation associated with increased invasion of cancer cells and a worse prognosis for 
patients (Barletta, Perner et al., 2009, Berghmans, Paesmans et al., 2006). This mucinous 
transformation in epithelial cancer cells is associated with expression of genes of the lower 
gastrointestinal tract such as HNF4A (Tata et al., 2018). Interestingly, while deletion of Nkx2-1 
resulted in expression of a portion of gastrointestinal genes, viral-induced deletion of Nkx2-1 in 
a KrasLSL-G12D mouse model for lung adenocarcinoma recapitulates the mucinous lung 
adenocarcinoma phenotype (Snyder et al., 2013, Winslow, Dayton et al., 2011). This switch in 
gene expression correlated with a shift of FOXA1/2 binding from pulmonary associated genes 
with its known interactor NKX2-1 to gastrointestinal genes (Snyder et al., 2013). Supporting 
this idea, deletion of Foxa1/2 in the presence of KrasLSL-G12D; Nkx2-1CKO/CKO lungs repressed the 
mucinous phenotype, shifting gene expression to mimic gene expression associated with cells of 
the transitional zone between the esophagus and the stomach (Camolotto et al., 2018). This 
suggests that NKX2-1 positively maintains the lung epithelial identity but does not direct which 
epithelial identity should be adopted in its absence. 
 Interestingly, NKX2-1 is rarely expressed in the alternate type of non-small cell lung 
cancer, squamous cell carcinoma. Instead, SOX2 is overexpressed in more than 80% of 
squamous cell carcinoma cases (Campbell, Alexandrov et al., 2016).  This overexpression of 
SOX2, coupled with loss of NKX2-1, correlates with expression of esophageal genes in 
squamous cell carcinoma cells of patients (Tata et al., 2018). A mouse model with amplification 
of Sox2 gene expression in Nkx2-1 mutant airway cells recapitulated expression of esophageal 
genes found in squamous cell carcinoma (Tata et al., 2018). However, deletion of Nkx2-1 in the 
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airway where Sox2 is regularly expressed, led to the mucinous phenotype similar to the deletion 
of Nkx2-1 carried out using viral induction described above (Tata et al., 2018). Taken together, 
NKX2-1 is required for development of the lung and maintenance of the AT2 cell identity in the 
mature lung, repressing alternative cell fates driven by the intrinsic repertoire of endodermal 
transcription factors expressed, and serves both a tumor suppressive and oncogenic role in lung 
cancer. This, in combination with the tractable abundance of alveolar epithelial cells and the 
dearth of knowledge driving AT1 or AT2 cell fate, make it an optimal lineage transcription 
factor to investigate in the context of binary cell fate decision in vivo whilst driving the field of 
lung biology forward.  
 
1.6 Dissertation Summary 
Cellular complexity in mammalian tissues comprised of distinct tissue lineages, and 
multiple cell types within each lineage, arises from the hierarchical deployment of transcription 
factors and their unique combinations throughout organ development. Within a family of cell 
types descending from a common progenitor, cells often express a lineage transcription factor 
that promotes and maintains each distinct cell fate. How such factors function and bind genome 
wide across cell types to orchestrate distinct, cell type-specific epigenomes within the lineage in 
vivo is unclear. Leveraging the abundance of cells within the alveolar epithelium in combination 
with precise genetic knockouts, cell type-specific ChIP-seq, and single-cell technology, we 
define the many in vivo functions of the lung lineage transcription factor NKX2-1 in binary cell 
fate decision, development, and maintenance of cell types within the alveolar epithelium. 
Specifically, our study shows that NKX2-1 is expressed and required for AT1 and AT2 identity, 
achieving this through cell type-specific binding guided by cell type-specific transcription 
factors. In the absence of these guides, NKX2-1 shifts to the alternative cell fate binding in 
coordination with a cell fate conversion. Strikingly, loss of Nkx2-1 resulted in a similar identity 
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crisis in which AT1 and AT2 cells broadly lost chromatin accessibility at their respective cell 
type-specific and lineage NKX2-1 binding sites and gained chromatin accessibility at a subset 
NKX2-1 sites specific to the alternate cell fate within the alveolar epithelium, followed by a 
switch to gastrointestinal epithelial lineage. These data suggest that in vivo, lineage transcription 
factors are essential, possessing a dual role – establishing and maintaining cell type and lineage 
identity, while repressing alternative alveolar and foregut identity for both. This study not only 
demonstrates that NKX2-1 establishes and maintains alveolar identities in coordination with cell 
type-specific transcription factors, but also establishes an experimental paradigm to investigate 
lineage transcription factors in vivo.   
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Chapter 2: Materials and Methods  
[Note: This chapter is based on published material from Little et al 2019 (Little, D. R., et al. 
Transcriptional control of lung alveolar type 1 cell development and maintenance by NK 
Homeobox 2-1, PNAS, doi: https://doi.org/10.1073/pnas.1906663116) and a manuscript that 
was deposited in bioRxiv, Little et al. 2020 (Little, D.R, et al. Lung lineage transcription factor 
NKX2-1 epigenetically resolves opposing cell fates in vivo, bioRxiv, doi: 
https://doi.org/10.1101/2020.09.15.298232) with all rights retained by the authors. PNAS articles 
are published under a CC BY license (Creative Commons Attribution 4.0 International License), which 
establishes that authors retain copyright in their articles.] 
 
2.1 Mouse strains 
The following mouse strains of mixed genetic backgrounds were used: Nkx2-1CKO (Kusakabe, 
Kawaguchi et al., 2006b), Yap1CKO (Reginensi, Scott et al., 2013), TazCKO (Reginensi et al., 
2013), Aqp5Cre (Flodby, Borok et al., 2010), Wnt3aCre (Yoshida, Assimacopoulos et al., 2006), 
ShhCre (Harfe, Scherz et al., 2004), HopxCreER (Jain, Barkauskas et al., 2015), Sox9CreER (Soeda, 
Deng et al., 2010), SftpcCreER (Rock, Barkauskas et al., 2011), SftpcCreERrtTA (Chapman, Li et al., 
2011), RosamTmG (Muzumdar, Tasic et al., 2007), RosaL10GFP (Heiman, Schaefer et al., 2008), 
RosaSun1GFP(Mo, Mukamel et al., 2015) and Rtkn2CreER (this study). The Rtkn2CreER knock-in allele 
was generated using CRISPR targeting via standard pronuclear injection(Behringer RR, 2014). 
Specifically, 400 nM gRNA (Synthego), 200 nM Cas9 protein (E120020-250 µg, Sigma), and 500 nM 
circular donor plasmid were mixed in the injection buffer (10 mM Tris pH 7.5, 0.1 mM EDTA). The 5’ 
homology arm in the donor plasmid was PCR amplified between 5’-
CCACTTGGATCCTGGGGATTGGAA and 5’-GATTTGAAAAGCGCGCCCCAGGGC; the 3’ 
homology arm was PCR amplified between 5’-AGGGGCAGCTGCTGAGGGGTCTCG and 5’-
CTTAACAGATCTCCATTTAGTTCA. The gRNA targeted 5’-GGCCGTGCCTTGCACCGAGATGG 
with the last 3 nucleotides being the PAM sequence and the start codon underlined and replaced by that 
of CreER used in Sox9CreER  (Soeda et al., 2010).  
When a vaginal plug was observed, that day was designated E1. Induction of Cre 
recombinase was achieved through intraperitoneal injection of tamoxifen (T5649, Sigma) 
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dissolved in corn oil (C8267, Sigma) with specific doses described in figure legends. 
Intraperitoneal injection of 100 µg of EdU was carried out 2 hr prior to sacrifice of mice. To 
exclude those with widespread recombination, Aqp5Cre mice were screened for non-specific 
embryonic recombination using GFP reporters. Mice were of mixed gender and investigators 
were not blind to the genotypes. Experimental variation was minimized by processing samples 
in the same tissue blocks or tubes. Power analysis was not carried out to determine sample sizes 
for experiments. Statistical analysis was predominantly carried out on individual cellular 
readout basis with hundreds of cells analyzed. Animal experiments were approved by the 
Institutional Animal Care and Use at Texas A&M Health Science Center Institute of 
Biosciences and Technology and MD Anderson Cancer Center. 
 
2.2 Immunostaining 
2.2.1 Section Staining 
Gravity drip inflation was performed as previously described with minor modifications(Yang et 
al., 2016). Mice were anaesthetized with Avertin (2,2,2 tribromoethanol, T48402, Sigma, 
dissolved in 2-methyl-2-butanol, A730-1, Fisher) and then perfused with phosphate buffered 
saline (PBS, pH 7.4) through the right ventricle. The lung was then inflated through a 
cannulated trachea with 0.5% paraformaldehyde (PFA; P6148, Sigma) in PBS at 25 cm H2O 
pressure followed by submersion fixation in 0.5% PFA at room temperature for 3-6 hr and 
washed in PBS overnight at 4 °C on a rocker. Fixed lungs were then dissected into lobes which 
were then either prepared for cryosectioning or used to cut strips for wholemount 
immunostaining. For cryosectioning, fixed lobes were cryoprotected in 20% sucrose in PBS 
containing 10% optimal cutting temperature compound (OCT; 4583, Tissue-Tek) overnight on a 
rocker at 4 °C and embedded in OCT the next day. Cryosections at 10 µm or 20 µm thickness 
were blocked in PBS with 0.3% Triton X-100 and 5% normal donkey serum (017-000-121, 
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Jackson ImmunoResearch) and incubated overnight in a humidified chamber at 4 °C with 
primary antibodies diluted with PBS with 0.3% Triton X-100. The next morning sections were 
washed with PBS in a coplin jar for 1 hr followed by a 1 hr room temperature incubation with 
donkey secondary antibodies (Jackson ImmunoResearch) as well as 4’,6’-diamidino-2-
phenylindole (DAPI) diluted 1:1000 in PBS with 0.3% Triton X-100. Another 1 hr wash in PBS 
was carried out and followed by mounting sections with Aquapolymount (18606, Polysciences) 
and imaged using a Nikon A1plus confocal microscope. To quench native reporter fluorescence, 
immunostained samples were fixed with 2% PFA for 1 hr and incubated with methanol 
containing 6% hydrogen peroxide (H1009, Sigma) for 20 min. EdU staining was performed 
after immunostaining using the Click-iT EdU Alexa Fluor 488 Imaging Kit (C10337, 
ThermoFisher). TUNEL staining was performed using the In Situ Cell Death Detection Kit, 
Fluorescein (11 684 795 910, Millipore Sigma) after immunostaining.  
 
2.2.2 Wholemount immunostaining 
Minor modifications were made to published protocols for wholemount immunostaining (Yang 
et al., 2016). Around 3 mm thick strips were cut from the edge of cranial and left lobes of lungs 
or 60 µm cryosections collected in a Petri dish of PBS. These tissues were blocked with 5% 
normal donkey serum (017-0000-121, Jackson ImmunoResearch) in PBS with 0.3% Triton X-
100 followed by incubation with primary antibodies diluted in PBS with 0.3% Triton X-100 on 
a rocker at 4 °C overnight. Tissues were then washed at room temperature three times with 
PBS+1% Triton X-100+1% Tween-20 (PBSTT) on a rocker for 1 hr. Donkey secondary 
antibodies and DAPI diluted in PBS with 0.3% Triton X-100 (1:1000) were added and 
incubated at 4 °C overnight on a rocker. The following day, strips were washed again with 
PBSTT then fixed with 2% PFA in PBS for at least 2 hr on a rocker. For tissues expressing 
green or red fluorescent protein, native fluorescence was quenched after immunostaining by 
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methanol containing 6% hydrogen peroxide (H1009, Sigma) overnight on a rocker at 4°C. 
Tissues were then mounted flat side facing the coverslip on Premium Beveled Edge microscope 
slides (8201, Premiere) using Aquapolymount (18606, Polysciences) between electrical tape to 
alleviate pressure from the coverslip on the tissue. After 24 hr to dry the Aquapolymount, strips 







antibody  Gene  species dilution company catalog # 
anti-aquaporin 5 AQP5 rabbit 1:2500 Abcam ab78486 
anti-protein tyrosine phosphatase, receptor 
type , C CD45 rat 1:2000 eBioscience 14-0451-81 
anti-CCAAT/enhancer binding protein alpha C/EBPA rabbit 1:500 
Cell Signaling 
Technology 8178P 
anti-cathepsin E CTSE rabbit 1:1000 Abcam ab36996 
anti-epithelial cadherin  ECAD rat 1:1000 
Life 
Technology 13190 
AF488 anti-epithelial cadherin  ECAD rat 1:500 Invitrogen 53-3248-82 
anti-green fluorescent protein  GFP chicken 1:5000 Abcam AB13970 
anti-homeodomain only protein  HOPX rabbit 1:500 Santa Cruz sc-30216 
anti-KI67 KI67  rat 1:1000  Invitrogen 14-5698-82 
eFluor 570 anti-KI67  KI67 rat 1:1000 eBioscience 41-5698-82 
anti-lysosomal associated membrane protein 3  LAMP3 guinea pig 1:500 SySy 391005 
anti-NK homeobox 2-1  NKX2-1 rabbit 1:1000 Santa Cruz sc-13040 
anti-podoplanin PDPN goat 1:1000 R&D AF3244 
anti-polymeric immunoglobulin receptor  PIGR goat 1:1000 R&D AF2800 
anti-receptor for advanced glycosylation end 
products  RAGE rat 1:1000 R&D MAB1179 
anti-pro-surfactant protein C  SFTPC rabbit 1:1000 Millipore AB3786 
 anti-trefoil factor 2  TFF2 rabbit 1:1000 Proteintech 13681-1-AP 
anti-Yes associated protein 1 and WW 
domain containing transcription regulator 1 
YAP1/ 
TAZ rabbit 1:250 
Cell Signaling 
Technology D24E4 
Fluorescence activated cell sorting antibodies 
PE/Cy7 anti-CD45  CD45 rat 1:250 BioLegend 103114 
PE anti-epithelial cadherin  ECAD rat 1:250 BioLegend 147304 
BV421 anti-epithelial cell adhesion molecule  EPCAM rat 1:250 BioLegend 118225 
AF647 anti-Intercellular adhesion molecule 2  ICAM2 rat 1:250 ThermoFisher A15452 
Chromatin immunoprecipitation antibodies 
anti-NK homeobox 2-1 NKX2-1 rabbit 1 µg Abcam ab76013 
anti-NK homeobox 2-1 NKX2-1 rabbit 1 µg Abcam ab133737 
anti-NK homeobox 2-1 NKX2-1 rabbit 1 µg Abcam ab133638 
anti-NK homeobox 2-1 NKX2-1 rabbit 1 µg Millipore 07-601 
anti-Histone 3 Lyine 4 tri-methylation H3K4me3 rabbit 1 µg Abcam ab8580 
anti-Histone 3 Lyine 4 mono-methylation H3K4me1 rabbit 0.6 µg Abcam ab8895 
anti-Histone 3 Lyine 27 acytelation H3K27ac rabbit 1 µg Abcam ab4729 
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Table 1. Antibodies used to complete this study 
A comprehensive table disclosing the specific antibodies and respective concentrations used for 
immunofluorescence, fluorescent activated cell sorting and chromatin immunoprecipitation.  
 
2.2.4 Cellular proliferation quantification 
To quantify cell proliferation using KI67 and EdU, confocal images were taken with a 40x oil 
objective on wholemount immunostained strips (318 µm x 318 µm x 20 µm; the Aqp5Cre, 
developing/maintenance HopxCreER, and SftpcCreER models) or sections (318 µm x 318 µm x 10 
µm; the Sox9CreER model). The Aqp5Cre and SftpcCreER models had the RosaSun1GFP reporter that 
allowed automated segmentation of the nuclei using Imaris to obtain the associated mean 
intensities of NKX2-1 and KI67 staining. Positive and negative cells were verified visually and 
re-assigned manually if needed. For both HopxCreER knockout models, cells were considered 
GFP positive if each slice for that cell showed its nucleus enveloped by GFP. For the Sox9CreER 
model, all ECAD positive cells were manually categorized for NKX2-1 and KI67 status. 
 
2.2.5 Cell perimeter quantification 
Confocal 512 x 512 x 30 pixel images were taken with a 40x oil objective with a field size of 
318 µm x 318 µm x 30 µm on wholemount immunostained lobe strips. Images were taken from 
the surface of alveoli to include all junctions of each complete AT1 cell. Five images were taken 
per lung with five GFP positive cells quantified per image in the Aqp5Cre knockout model with 
four cells selected from each image quadrant and one cell from the center. Only NKX2-1 
negative GFP positive cells were quantified in the mutant. For the HopxCreER knockout model 
during development, at least 10 cells were quantified per mouse with only NKX2-1 negative 
AT1 cells quantified in the mutant. In both models, the ECAD staining associated with the cell 
of interest was traced manually to obtain its cell perimeter using Imaris (Bitplane version 7.7.2). 
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To image cells in the Sox9CreER knockout model, mutant and control strips were imaged at a 
resolution of 1024 x 1024 x 30 pixel for analysis in the Z plane.   
 
2.2.6 Mean linear intercept (Lm) and H&E staining 
Mean linear intercept was determined on 5 µm frozen lung sections stained with hematoxylin 
and eosin (H&E). Five images were acquired for each lung using an upright Olympus BX60 
microscope with a 10x objective and then Lm (Campbell & Tomkeieff, 1952, Dunnill, 1964, 
Liu, Fu et al., 2017) was quantified using the ruler tool in Adobe Photoshop. At least 20 
intercepts per image were measured, which required two horizontal and two vertical grid lines 
for the mutants and one horizontal and one vertical grid line for the controls. One intercept was 
defined as the distance from one alveolar wall to the next along the grid lines. Airway and 
vessel lumens and alveoli on the edge of images were excluded from the analysis. The average 
from the five images (Lm) was used to represent each lung.  
 
2.3 Scanning Electron Microscopy and Transmission Electron Microscopy 
For electron microscopy one pair of littermate control and mutant lungs per time point were 
inflated at 25 cm H2O pressure and fixed with a solution containing 3% glutaraldehyde plus 2% 
paraformaldehyde in 0.1 M cacodylate buffer, pH 7.3. Fixed lungs were washed with 0.1 M 
cacodylate buffer, pH 7.3, post fixed with 1% cacodylate buffered osmium tetroxide, washed 
with 0.1 M cacodylate buffer, then in distilled water. Afterwards, the samples were sequentially 
treated with Millipore-filtered 1% aqueous tannic acid, washed in distilled water, treated with 
Millipore-filtered 1% aqueous uranyl acetate, then rinsed thoroughly with distilled water. The 
samples were dehydrated with a graded series of increasing concentrations of ethanol, then 
transferred to a graded series of increasing concentrations of hexamethyldisilazane (HMDS) and 
air dried overnight. Samples were mounted on to double-stick carbon tabs (Ted Pella. Inc., 
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Redding, CA), which were previously mounted on to aluminum specimen mounts (Electron 
Microscopy Sciences, Ft. Washington, PA). The samples were then coated under vacuum using 
a Balzer MED 010 evaporator (Technotrade International, Manchester, NH) with platinum alloy 
for a thickness of 25 nm, then immediately flash carbon coated under vacuum. The samples 
were transferred to a desiccator for examination at a later date. Samples were examined/imaged 
in a JSM-5910 scanning electron microscope (JEOL, USA, Inc., Peabody, MA) at an 
accelerating voltage of 5 kV. For transmission electron microscopy one pair of littermate control 
and mutant lungs per time point were inflated at 25 cm H2O pressure and fixed with a solution 
containing 3% glutaraldehyde plus 2% paraformaldehyde in 0.1 M cacodylate buffer, pH 7.3, 
then washed in 0.1 M sodium cacodylate buffer and treated with 0.1% Millipore-filtered 
cacodylate buffered tannic acid, postfixed with 1% buffered osmium, and stained en bloc with 
1% Millipore-filtered uranyl acetate. The samples were dehydrated in increasing concentrations 
of ethanol, infiltrated, and embedded in LX-112 medium. The samples were polymerized in a 60 
ºC oven for approximately 3 days. Ultrathin sections were cut in a Leica Ultracut microtome 
(Leica, Deerfield, IL), stained with uranyl acetate and lead citrate in a Leica EM Stainer, and 
examined in a JEM 1010 transmission electron microscope (JEOL, USA, Inc., Peabody, MA) at 
an accelerating voltage of 80 kV. Digital images were obtained using an AMT Imaging System 
(Advanced Microscopy Techniques Corp, Danvers, MA). 
 
2.4 Cell dissociation and sorting 
Mice were anesthetized and perfused as described above. Lungs were dissected in PBS free of 
extra-pulmonary airways and connective tissue, and then minced with forceps and digested in 
RPMI media (ThermoFisher, 11875093) for bulk RNA-seq or Liebovitz media (Gibco, 21083-
027) for scRNA-seq, ATAC-seq, and scATAC-seq with 2 mg/mL collagenase type I 
(Worthington, CLS-1, LS004197), 2 mg/mL elastase (Worthington, ESL, LS002294), and 0.5 
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mg/mL DNase I (Worthington, D, LS002007) for 30 min at 37 °C.  Fetal bovine serum (FBS, 
Invitrogen, 10082-139) was added to a final concentration of 20% to stop the digestion. The 
tissues were transferred to the cold room on ice, triturated until homogenous, and then filtered 
through a 70 µm cell strainer (Falcon, 352350). This was then transferred to a 2 mL tube and 
centrifuged at 1,537 rcf for 1 min then resuspended with red blood cell lysis buffer (15 mM 
NH4Cl, 12 mM NaHCO3, 0.1 mM EDTA, pH 8.0) for 3 min and centrifuged again as before. 
This step was repeated to remove residual red blood cells. Samples were then washed with 
RPMI+10% FBS for bulk RNA-seq or Liebovitz+10% FBS for scRNA-seq and ATAC followed 
by filtration through a 35 µm cell strainer into a 5 mL glass tube. Bulk RNA-seq and bulk 
ATAC-seq were then then washed and resuspended with RPMI+10% FBS and had SYTOX 
Blue (1:1000, Invitrogen, S34857) added. Samples were then refiltered and sorted based on a 
RosaL10GFP reporter for Aqp5Cre or a RosaSun1GFP reporter for SftpcCreER, SftpcCreERrtTA, or 
Wnt3aCre without antibody staining on a BD FACSAria IIIu cell sorter with a 70 µm nozzle. 
Samples for scRNA-seq or scATAC-seq were stained with CD45-PE/Cy7 (BioLegend, 
103114), ECAD-PE (BioLegend, 147304), and ICAM2-A647 (Invitrogen, A15452) antibodies 
(1:250 dilutions for all antibodies) for 30 min. Samples for verification of the ECAD antibody 
based sorting were incubated with CD45-PE/Cy7 (BioLegend, 103114), ECAD-PE, and 
EPCAM-BV421 (BioLegend, 118225). Samples were then washed and resuspended with 
Liebovitz media+10% FBS and SYTOX Blue. Samples were then refiltered and sorted using a 
BD FACSAria Fusion sorter with a 70 µm nozzle.  
 
2.5 RNA-seq and scRNA-seq  
2.5.1 Bulk RNA-seq library preparation and sequencing 
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RNA from sorted GFP positive AT1 or AT2 cells was extracted using Trizol reagents 
(Invitrogen, 15596018) followed by the RNeasy Micro kit (Qiagen, 74004). Gel electrophoresis 
and RT-PCR using the SuperScript IV First-Strand Synthesis System (Invitrogen, 18091050) 
were used to verify RNA quality and purity. 100 ng of total RNA was then used to prepare an 
RNA-seq library using an mRNA isolation kit (New England BioLabs, E7490) and NEBNext 
Ultra RNA library prep kit (New England BioLabs, E7530S). The libraries were then amplified 
with indexing primers (New England BioLabs, E7335S or E7500S) followed by a double-sided 
(.65 x -1 x volume) size selection step using a SPRIselect reagent kit (Beckman Coulter, 
B23318). Libraries were then sequenced on an Illumina NextSeq500 with at least 20 million 150 
bp paired-end reads per sample. Reads were then aligned to the UCSC mm10 reference genome 
using tophat2 and bowtie2 suite (Kim, Pertea et al., 2013, Langmead & Salzberg, 2012) 
followed by transcript abundance, differential expression, and isoform quantitation calculated 
using the cufflinks suite (Roberts, Pimentel et al., 2011, Roberts, Trapnell et al., 2011, Trapnell, 
Hendrickson et al., 2013, Trapnell, Roberts et al., 2012, Trapnell, Williams et al., 2010). A 
small FPKM value (1) was added to all measurements to allow logarithmic transformation. Bulk 
RNA-seq processing was carried out by Edwin J. Ostrin for RNA collected from the Aqp5Cre 
Nkx2-1 deletion model. Raw data was deposited in GEO under the accession number 
GSE129628. RNA-seq datasets (Little, Gerner-Mauro et al., 2019) for deletion of Nkx2-1 in 
AT1 and AT2 cells during development were used to analyze expression of genes associated 
with 10% of sites (boxed in Fig. 7a) with increased chromatin accessibility in NKX2-1Rtkn2 and 
NKX2-1Sftpc mutants.  
 
2.5.2 scRNA-seq  
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Sorted epithelial cells were processed on the Chromium Single-Cell Gene Expression Solution 
Platform (10X Genomics) using the Chromium Single-Cell 3’ Library and Gel Bead Kit 
following the manufacturer’s user guide (v2, rev D). Libraries were then sequenced using 
Illumina NextSeq500 with a 26 X 124 format with 8 bp index (Read1). scRNA-seq output was 
then processed using Cell Rangers “cellranger count” and “cell ranger aggr”.  Downstream 
analyses were carried out using the Seurat R package and custom R scripts. Seurat 
(https://satijalab.org/seurat/pbmc3k_tutorial.html) was used to remove cells with fewer than 200 
detected genes and cells with unique gene counts over 5000 or less than 200. No mitochondrial 
genes were found. After filtering, log normalization, identification of highly variable genes, 
scaling, and PCA dimensionality reduction, graph-based clustering was carried out. The 
identified clusters were then analyzed for differentially expressed genes and tSNE plots were 
made with Ptprc, Col3a1, Icam2, and Cdh1 to identify the four originally sorted cell lineages 
and isolate epithelial cells for further graph-based clustering. Mutant AT1 cells were identified 
based on lack of Nkx2-1 expression since its 3’ untranslated region was deleted and thus 
undetectable by the 10x Genomics sequencing platform (Fig. 6A). The gene barcode matrix was 
then extracted using custom R scripts for control AT1 and AT2 cells as well as both early and 
late mutant AT1 cells using Seurat based on cell type-specific markers. These gene barcode 
matrices were then compared to the single-cell mouse cell atlas 
http://bis.zju.edu.cn/MCA/blast.html (Han, Wang et al., 2018). The output was cropped to show 
the 15 most correlated cell types. Raw data was deposited in GEO under the accession number 
GSE129628. 
 
2.5.3 Pseudotemporal analysis 
Monocle 2.8.0 (Qiu, Hill et al., 2017a, Qiu, Mao et al., 2017b, Trapnell, Cacchiarelli et al., 
2014) was used to analyze the aggregate file of Aqp5Cre Nkx2-1 control and mutant mice 
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(performed by Kamryn N. Gerner-Mauro) from CellRangerRkit 2.0.0. Cell normalization, 
variance estimate, and outlier removal were carried out following the default settings. For the 
initial clustering, genes were selected with a mean expression >0.1 and were clustered into 19 
clusters. Multiple dimensions were used for the principal component analysis (PCA) and 
compared using the adjusted rand index. PCA was performed using 10 dimensions for the final 
run. Dimensions were reduced by tSNE and distinct lung cell types were identified by known 
gene markers. AT1 cells from either the control or mutant lung were selected from clusters 
expressing Cdh1 (epithelial cells) but not Lamp3 (AT2 cells), Foxj1 (ciliated cells), or Scgb3a2 
(club cells). The proliferating mutant AT1 cell cluster (Mki67) was also excluded because its 
gene signature was dominated by proliferation genes. Dimensions were reduced with the same 
parameters as previously described on the subset of epithelial cells and the cells were clustered. 
From these clusters, the differentially expressed genes were extracted and ordered by q-value. 
The data was reduced again by DDRTree, and the pseudotime trajectory was created for control 
and mutant AT1 cells using the top 100 differentially expressed genes. From the 
pseudotemporal analysis, the top 1000 differentially expressed genes over pseudotime (998 
genes returned by Monocle) were used to generate a heatmap of gene patterns along the 
pseudotemporal trajectory from control to mutant AT1 cells.  
 
2.6 Chromatin accessibility  
2.6.1 Bulk ATAC, sequencing, and processing 
The OMNI-ATAC protocol(Corces, Trevino et al., 2017) was followed with minor 
modifications. 60,000-100,000 sorted GFP cells were centrifuged at 384 rcf for 5 min at 4 °C. 
The cell pellet was then resuspended by pipetting three times in 50 µl of cold ATAC-RSB lysis 
buffer (0.1% NP-40, 0.1% Tween, 0.01% Digitonin, 10 mM Tris-HCl pH 8.1, 10 mM NaCl, 3 
mM MgCl2) and incubated for 3 min. Then 1 mL of cold ATAC-RSB + Tween (10 mM Tris-
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HCl pH 8.1, 10 mM NaCl, 3 mM MgCl2, 0.1% Tween) was added. The sample tube was then 
inverted three times and centrifuged at 384 rcf for 10 min at 4 °C. After discarding the 
supernatant, the pellet was resuspended in transposition mixture composed of 22.5 µl of 
Reaction Mix (PBS, 2.2% Digitonin, 2.2% Tween 20), 25 µl of transposase buffer (10 mM 
MgCl2, 20mM Tris- HCl, 20% Dimethyl Formamide), and 2.5 µl of Tn5 enzyme (NX#-TDE1, 
Tagment DNA Enzyme,15027865, Illumina) and incubated at 37 °C for 30 min in a 
thermocycler. Samples were then purified using the MinElute PCR Purification kit (Qiagen, 
29004) and eluted with 10 µL of H2O. Amplification and barcoding of ATAC libraries was 
carried out using the Greenleaf primers for 12 cycles of PCR enrichment following the standard 
OMNI-ATAC amplification PCR program. A volume of 5 µL was taken after amplification to 
examine amplification efficiency prior to size selection. A double-sided size selection was then 
performed (.5 x -1.8 x volume) using the SPRIselect reagent (Beckman Coulter, B23318). 
Samples were then verified for library size and absence of primer dimers by gel electrophoresis 
and concentration was measured using the Qubit HS dsDNA assay (ThermoFisher Scientific, 
Q32851). Samples were then sequenced on the Illumina NextSeq500 with at least 20 million 75 
bp paired-end reads per sample. Reads were then demultiplexed using BCL2Fastq with the 
setting of a -- barcode-mismatches 0 or 1 and then assessed for read quality with FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/), trimmed with Trimmomatic 
(Bolger, Lohse et al., 2014), and aligned to the UCSC mm10 reference genome by bowtie2 
(Kim et al., 2013, Langmead & Salzberg, 2012) using default settings.  After alignment, sam 
files were converted to bam files and filtered for unmapped reads(Li, Handsaker et al., 2009), 
PCR duplicates, singletons, chimeric alignments, and low quality aligned reads using picard 
MarkDuplicates and samtools settings: –f 3 –F 4 –F 256 –F 1024 –F 2048 –q 30(2019). Peaks 
were called using MACS2 settings: -q 0.05 –nomodel –shift -100 –extsize 200 –broad (Feng, 
Liu et al., 2012, Zhang, Liu et al., 2008). Called sites for ATAC samples were filtered at a -log10 
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q-value greater than 5, and sites overlapping with the mm10 blacklist were discarded. 
Differentially accessible sites were identified using DiffBind(Ross-Innes, Stark et al., 2012) 
normalized for sample read depth and with a fixed peak width of 500 bp between control versus 
mutants and AT1 versus AT2 samples. Foreground normalization was carried out using the 
fractions of reads in peaks (Frip) calculated by DiffBind for all peaks in each ATAC-seq 
sample. These Frip values were then multiplied by the post-filtering library read depth to scale 
MACS2 output bedgraph files and profile plots, tracks, and heatmaps in EA-seq (Lerdrup, 
Johansen et al., 2016). 
 
2.6.2 scATAC-seq processing pipeline 
Cells were sorted from 7-week-old mice as described above and processed using the 3’ Library 
and Gel Bead Kit following the manufacturer’s users guide (v2 rev D) on the Chromium Single 
Cell Gene Expression Solution Platform (10X Genomics). Libraries were then sequenced using 
Illumina Novaseq6000 with a 50-paired-end format with index1 for 8 cycles and index2 for 16 
cycles. The output was processed using Cell Ranger ATAC’s functions “cellranger-atac count”. 
Downstream analysis was performed using Seurat R package (v3) (website info), Signac v 0.1.5 
(https://github.com/timoast/signac) and custom R scripts. Cells were filtered out if the unique 
peak counts were over 100,000 or less than 1,000 accessible sites, lower than 25% of reads were 
in peaks, or they had higher than 0.025 blacklist ratio or higher than 10 nucleosome signal, or a 
transcription start site enrichment less than 2. After cell clustering, gene activities were 
calculated using the 2000 bp upstream and downstream from the transcription start site. The 
following genes activity score was used to identify cell types: Spock2 for AT1, Lamp3 for AT2, 
Sox2 for airway (cross referenced with Foxj1, Scgb1a1, and Trp63), Plvap for PLVAP 
endothelial cells, Car4 for CAR4 endothelial cells, Cd79a for B cells, Cd3e for T cells, Ccl4 for 
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NK cells, Cd9, Ear1, and Cd300e for alveolar macrophages, Cd9 and S100a9 for neutrophils, 
Cd300e for monocytes, Msln for mesothelial cells, Cdh4 and Fgf18 for Wnt5a cells, Acta2 and 
Actc1 for alveolar smooth muscle cells, Pdgfra and Meox2 for interstitial cells, and Pdgfrb and 
Notch3 for pericytes. Clusters with most cells accessible across all genes were excluded from 
analysis. To classify cell types into lineages, the following genes were used in addition to cell 
type information: Nkx2-1 and Epcam for epithelial cells, Cdh5 for endothelial, Runx1 for 
immune, and Tbx4 for mesenchymal. After cell type and lineage identification, cell barcodes 
were exported to a text file for each lineage. These barcodes were used to subset the 
posssorted_bam.bam files output from the “cellranger-atac count” function using the program 
Sinto into the epithelial, endothelial, immune, and mesenchymal lineages 
(https://github.com/timoast/sinto). Sinto was also used to randomly subset the 
possorted_bam.bam into 2 pseudo-bulk files, resulting in 8 files for the 4 lineages. All files were 
then filtered for unmapped reads, PCR duplicates, singletons, chimeric alignments, and low 
quality aligned reads using picard MarkDuplicates and samtools commands: –f 3 –F 4 –F 256 –
F 1024 –F 2048 –q 30. Peaks were called on full lineage sets using MACS2 commands: -q 0.05 
–nomodel –shift -100 –extsize 200 --broad. Called sites for ATAC samples were filtered at a -
log10 q-value greater than 2 and sites overlapping with the mm10 blacklist were discarded. To 
compare accessible sites between lineages, DiffBind was used on the two filtered pseudo-bulk 
lineage bam files using the peaks called for each full lineage set. To verify DiffBind output, 
Sinto was used to subset the possorted_bam.bam into bam files for each individual cell type. 
They were then filtered using the same parameters above and analyzed using MACS2 with the 
parameters above. The Frip values generated by DiffBind for cell types and lineages were 
multiplied by the associated post-filtering library depth and used for foreground normalization 
to scale the tracks and heatmaps in EA-seq. Visualization of lineage differential chromatin 
accessibility analysis showed that while statistical significance was not achieved due to 
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variations within the endothelial, immune, and mesenchymal lineages, a log2 fold change of 1 
was sufficient to qualitatively distinguish epithelial lineage versus housekeeping sites. 
 
2.7 Chromatin Immunoprecipitation 
2.7.1 Isolation of nuclei 
Lungs were harvested from Avertin anesthetized mice after perfusing 3 mL of cold PBS through 
the right ventricle. Lungs were minced after removal of extra-pulmonary tissues. The tissue was 
then crosslinked for 20 min on a rocker at room temperature using a 1:4 PBS diluted 10% 
buffered formalin (ThermoFisher Scientific, 23-245-685). To quench the excess fixative, 1 M 
glycine (pH 5.0) was added to a final concentration of 125 mM and incubated at room 
temperature on a rocker for 5-10 min. The fixed tissue was then washed with 2 mL cold PBS 
and resuspended with 1 mL (500 µL for embryos) of isolation of nuclei tagged in specific cell 
types (INTACT16) buffer (20 mM HEPES pH 7.4, 25 mM KCl, 0.5 mM MgCl2, 0.25 M 
sucrose, 1 mM DTT, 0.4% NP-40, 0.5 mM Spermine, 0.5 mM Spermidine) with protease 
inhibitor cocktail (cOmplete ULTRA Tablets, Mini, EDTA-free, EASY pack, Milipore Sigma, 
5892791001 or Pierce Protease Inhibitor Mini Tablets, EDTA-free, ThermoFisher Scientific, 
A32955). Resuspended samples were then dounce homogenized for 5 strokes, filtered through a 
70 µm cell strainer, and centrifuged in a 2 mL tube at 384 rcf for 5 min. Samples were then 
resuspended in PBS plus protease inhibitor cocktail and either sorted for cell type-specific ChIP-
seq or counted for whole lung ChIP-seq. For cell type-specific ChIP-seq, nuclei were stained 
with Sytox blue (1:1000, Invitrogen, S34857) then filtered through a 35 µm cell strainer into a 5 
mL glass tube (12x75mm Culture Tubes with closures volume 5 mL, VWR, 60818-565) 
blocked with 200 µL 10 mg/mL BSA (FBS, Invitrogen, 10082-139) and 1x protease inhibitor 
cocktail. Nuclei were then sorted at 4°C using an BD FACSAria Fusion sorter or BD FACSAria 
IIIu cell sorter for GFP positive nuclei from the RosaSun1GFP allele and Sytox blue positive nuclei 
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into a 1.7 ml collection tube containing and blocked with 300 µL of 10 mg/mL BSA with 5x 
protease inhibitor cocktail. Wnt3aCre/+; RosaSun1GFP/+ mice rendered ~1 million nuclei per lung. 
SftpcCreER/+; RosaSun1GFP/+ mice rendered 1-2 million nuclei per lung. For a full set of histones 
ChIPs in addition to an NKX2-1 ChIP, nuclei from lungs of mice with the same genotype were 
combined. If samples were combined, a second experiment with different mice of the same 
genotype and time point would be performed for a biological replicate. 
 
2.7.2 Whole lung chromatin immunoprecipitation 
Nuclei collected from whole lung samples were counted and 1 million nuclei aliquots were 
added to six 1.7 mL tubes (Olympus plastics, 24-282) for P10 ChIP. For each E14.5 sample 1 
million nuclei were collected by combining 2-3 lungs for each replicate to make 1 million nuclei 
per replicate. These samples were then centrifuged at 384 rcf for 5 min. The pellet was 
resuspended in 100 µL ChIP nuclei lysis buffer (50 mM Tris-HCl pH 8.1, 10 mM EDTA, 1% 
SDS with 1x protease inhibitor cocktail). After incubation on ice for 15 min, samples were then 
sonicated using a Bioruptor Twin (Diagenode, UCD-400-TO) in a 4 °C cold room on the high 
setting for 37 cycles of 30 seconds on 30 seconds off to achieve DNA fragment size of 200-
500bp. The samples were then centrifuged at 12,052 rcf for 15 min at 4°C. The supernatant from 
each tube was pooled to a total volume of 600 µL for P10 and 100 µL per E14.5 replicate. From 
this chromatin, 20 µL of the sample was taken as an input control, diluted with Tris-EDTA (TE) 
buffer (1 mM EDTA, 10 mM Tris-HCl pH 8.1), and stored at -80°C. The remaining chromatin 
was diluted to 1 mL with ChIP dilution buffer (16.7 mM Tris-HCl pH 8.1, 1.2 mM EDTA, 1.1% 
Triton X-100, 0.01% SDS with 1x protease inhibitor cocktail) and precleared with 40 µL 
Protein G Dynabeads (ThermoFisher Scientific, 10004D) in a 2 mL tube for 1 hr on a rotator at 
4°C. For E14.5 ChIP, preclear beads were blocked for 1 hr on a rotator with 500 µL ChIP 
dilution buffer with the addition of 200 µL 25 mg/mL Bovine Serum Albumin (Jackson 
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ImmunoResearch, 001-000-161), and 4 µL 10 mg/mL Salmon DNA Sperm (Invitrogen, 15632-
011). P10 precleared chromatin was divided into four tubes (250 µL/tube) and diluted to 1 mL 
with ChIP dilution buffer such that roughly 1 million nuclei were incubated with 1 µg of each 
NKX2-1 antibody overnight at 4 °C on a rotator. E14.5 chromatin was diluted to 1 mL with 
ChIP dilution buffer then incubated with 1 µg of NKX2-1 antibody (Abcam ab133737) 
overnight at 4 °C on a rotator. Concurrently, 30 µL protein G Dynabeads for each antibody were 
blocked overnight at 4 °C on a rotator in 500 µL ChIP dilution buffer with the addition of 200 
µL 25 mg/mL Bovine Serum Albumin and 4 µL 10 mg/mL Salmon DNA Sperm. The next 
morning, the blocked beads were washed with ChIP dilution buffer twice and transferred to new 
2 mL tubes. The antibody-chromatin solution was added and incubated for 3 hr at 4 °C while 
rotating. The dynabeads were then isolated using a magnetic adaptor and washed with 1 mL of 
each of the following buffers for 5 min each on a rotator: low salt buffer (150 mM NaCl, 2 mM 
EDTA, 1% Triton X-100, 20 mM Tris-HCl pH 8.1, 0.1% SDS), high salt buffer (500 mM NaCl, 
2 mM EDTA, 1% Triton X-100, 20 mM Tris-HCl pH 8.1, 0.1% SDS), lithium chloride buffer 
(250 mM LiCl, 1 mM EDTA, 1% NP-40, 10 mM Tris-HCl pH 8.1, 0.1% sodium deoxycholate) 
twice and TE buffer twice. The resuspended sample after the second TE wash was transferred to 
fresh 2 mL tubes and a magnetic adaptor was used to collect the dynabeads and 300 µL fresh TE 
was added. The samples and the frozen input chromatin were then incubated at 37 °C with 1.5 
µL of 10 mg/mL RNase A (Qiagen, 1007885) for 1 hr, followed by a 4 hr incubation at 55 °C 
after adding 3.5 µL of 20 mg/mL Proteinase K (ThermoFisher Scientific, EO0491) and 15 µL of 
10% SDS. The incubation continued overnight at 65 °C to reverse the crosslinking. DNA 
extraction was then performed by adding 1 volume of phenol:chloroform:isoamyl alcohol 
solution (Sigma, P2069-400ML) followed by centrifugation at 12,052 rcf for 15 min. DNA in 
the upper phase was precipitated by adding 2 volumes of 100% ethanol, 1/10 volume of 3 M 
NaCl and 3 µL of 20 µg/µL glycogen (Invitrogen, 10814-010). The solution was then vortexed 
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briefly and centrifuged for 30 min at 12,052 rcf in a 4 °C cold room. The pellet was washed with 
70% ethanol without resuspension. The sample was then centrifuged for 5 min at 9,200 rcf at 
room temperature. The pellet was air dried for 10 min and dissolved in 10 µL nuclease-free 
ddH2O.  
 
2.7.3 Cell type-specific chromatin immunoprecipitation 
The published method for chromatin immunoprecipitation was used with minor 
modifications(Little et al., 2019). Whole lung samples or sorted nuclei were split into aliquots of 
1 million nuclei per 1.7 mL tube. Nuclei were then centrifuged at 12,052 rcf for 10 min at 4 °C. 
The supernatant was discarded and the visible pellet in each aliquot was then resuspended in 
100 µL of ChIP nuclei lysis buffer (50 mM Tris-HCl pH 8.1, 10 mM EDTA, 1% SDS with 1x 
protease inhibitor cocktail) and incubated for 15 min at 4 °C. Concurrently, two sets of Protein 
G Dynabeads (ThermoFisher Scientific, 10004D) were blocked with 200 µL 20 mg/mL bovine 
serum albumin (Jackson ImmunoResearch, 001-000-161), 4 µL 10 mg/mL salmon sperm DNA 
(Invitrogen, 15632-011), and ChIP dilution buffer (16.7 mM Tris-HCl pH 8.1, 1.2 mM EDTA, 
1.1% Triton X-100, 0.01% SDS with 1x protease inhibitor cocktail). The first set of beads 
consisted of 40 µL of Protien G Dynabeads per sample was blocked for 1 hr on a rotator for use 
in preclearing the chromatin. The second set with 30 µL protein G Dynabeads per antibody for 
ChIP was blocked on a rotator overnight a 4 °C. Nuclei were sonicated at 4°C using a Bioruptor 
Twin (Diagenode, UCD-400-TO) for 38 cycles of 30 sec on 30 sec off on the high setting for a 
target DNA fragment size of 200-500 bp. Samples were then pooled if they originated from the 
same sample to make one set of antibodies (NKX2-1, H3K4me3, H3K4me1, H3k27ac, and 
H3K27me3) for a genotype, which would be considered 1 replicate for the respective 
antibodies. Samples were then centrifuged at 4 °C at 12,052 rcf for 15 min. Concurrently, the 
first set of blocked Protein G Dynabeads was washed twice with ChIP dilution buffer using the 
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magnetic adaptor and transferred to a fresh 2 mL tube. Two 20 µL inputs were added to 300 µL 
of Tris-EDTA (TE) buffer (10 mM Tris-HCl pH 8.1, 1 mM EDTA) and stored overnight at -80 
°C. The remaining chromatin was added to the washed blocked Protein G Dynabeads, diluted to 
1 mL with ChIP dilution buffer, and precleared on a rotator for 1 hr at 4 °C. With a magnetic 
adaptor, chromatin was split into fresh 2 mL tubes for incubation with antibodies overnight and 
diluted to 1 mL with ChIP dilution buffer as necessary. The next morning, the second set of 
blocked Protein G Dynabeads was washed using ChIP dilution buffer twice and transferred to 
fresh 2 mL tubes, to which the antibody-chromatin solution was added. The sample preparation 
from this step forward is similar to whole lung ChIP.  
 
2.7.4 Library preparation and sequencing 
ChIP DNA quantity was measured using the Qubit dsDNA HS Assay Kit (Invitrogen, Q32851). 
2-5 ng of sample DNA was used to generate sequencing libraries using the NEB Next Ultra II 
DNA Library Prep Kit for Illumina (NEB, E7645). Step 3.1 in the NEB protocol was skipped to 
improve sample retention per manufacturer’s recommendation. Samples were PCR amplified 
for 12 cycles and barcoded using indexing primers (New England BioLabs, E7335s or E7500S) 
followed by a double-sided (.65 x -1 x volume) size selection and purification step using the 
SPRIselect reagent (Beckman Coulter, B23318). Samples were then verified for library size by 
gel electrophoresis and concentration measured using the Qubit HS dsDNA assay. Samples 
were then sequenced on the Illumina NextSeq500.  
 
2.7.5 Chromatin immunoprecipitation processing pipeline 
Reads of the same barcode from the four sequencing lanes were merged and processed using 
FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Trimmomatic was used to 
remove barcode sequences, followed by a second round of quality checking using FastQC. 
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Reads were then aligned using Bowtie with the parameters –m1 –k1 –v1 and filtered for 
unmapped reads. The filtered reads in sam files were converted to bam files using Samtools. 
Samples for P10 whole lung ChIP-seq were not filtered further. The remaining samples were 
filtered for unmapped reads, chimeric alignments, low quality alignments, and PCR duplicates 
using picard(2019) MarkDuplicates and samtools settings: -b -h -F 4 -F 1024 -F 2048 -q 30. 
Bam files were analyzed using SPP cross correlation (Kharchenko, Tolstorukov et al., 2008, 
Landt, Marinov et al., 2012). All samples passed the ENCODE standards for normalized strand 
coefficient (NSC) and relative strand correlation (RSC) (Landt et al., 2012). P10 whole lung 
ChIP-seq peaks were called using MACS2 with the --scaleup option for P10 whole lung ChIP-
seq to compensate for a low level of uniquely mapped reads in the input. Peaks were called in 
the remaining samples using MACS2 with the default settings for NKX2-1, H3K4me3, and 
H3K27ac, and the –broad setting for the broad histone mark H3K4me1. Filtered bam files were 
used to generate heatmaps in EA-seq centered on peaks from the Abcam 133737 antibody. 
Called peaks for individual NKX2-1 antibodies were compared pairwise using IDR to compute 
the self-consistency and self-rescue ratio(Li, Brown et al., 2011). All samples passed the 
ENCODE standard for the self-consistency ratio and the self-rescue ratio. Abcam 133737 and 
Upstate 07-601 antibodies were selected for further analysis. 61.6% of peaks over the standard 
transcription factor cut off of 540 had the highest IDR score of 1000. Therefore, only peaks with 
an IDR score of 1000 were used for subsequent analysis. The remaining ChIP-seq samples 
MACS2 peaks were then filtered based on the -log10 q-value as follows: 10 for NKX2-1, 15 for 
H3K4me3 and H3K27ac, and 4 for H3K4me1. Subsequent peaks were then filtered for sites 
overlapping with the mm10 blacklist. 
 
2.7.6 Post-processing ChIP-seq analysis  
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P10 NKX2-1 ChIP-seq peaks from Abcam ab133373 and Upstate 07-601 were analyzed for 
enriched binding motifs using HOMER (Heinz, Benner et al., 2010) and also annotated to the 
nearest genes, which were compared with the five gene lists derived from the Monocle 
pseudotemporal analysis. To directly compare genes with annotated peaks, the Abcam 
ab133737 and Update 07-601 ChIP bam files were first merged and then normalized to the input 
file using the SES method on deepTools2 (Ramirez, Ryan et al., 2016). For each group of genes, 
a profile plot was generated by averaging the read depth within 5 kb of each peak associated 
with the corresponding genes. This average was then scaled by multiplying this value by the 
average number of peaks per gene for genes that have peaks and plotted using 
deepTools2(Ramirez et al., 2016). Examples of NKX2-1 peaks were plotted with EA-seq using 
filtered bam files (Lerdrup et al., 2016). Raw data was deposited in GEO under the accession 
number GSE129628. The remaining ChIP-seq peaks were analyzed to identify differentially 
NKX2-1 bound peaks were identified using DiffBind normalized for sample read depth and at a 
fixed peak width of 500 bp between controls versus mutants, AT1 versus AT2, and E14.5 whole 
lung versus other time points in AT1 and AT2 cells. Quantification of histone marks between 
AT1 and AT2 cells at NKX2-1 bound sites was carried out also using DiffBind normalized for 
sample read depth but with a fixed peak width of 1000 bp. Foreground normalization was 
carried out using the fractions of reads in peaks (Frip) calculated by DiffBind for all peaks in 
each sample of the same antibody type. These Frip values were then multiplied by the post-
filtering library read depth to scale MACS2 output bedgraph files as well as profile plots, tracks, 
and heatmaps in EA-seq. HOMER motif analysis(Heinz et al., 2010) was carried out to 
determine possible co-factors interacting with NKX2-1 for all peaks associated with the list. 
Additional motif analysis was carried out on the bottom 3000 NKX2-1 peaks accessible across 
all cell types with the lowest H3K4me3 average signal. NKX2-1 binding peaks were 
consolidated from NKX2-1 ChIP-seq at E14.5, in mature AT1 cells, and in mature AT2 cells 
 38 
and used for differential analysis of NKX2-1 binding sites between E14.5 and AT1 or AT2 
cells. This consolidated peakset was then cross-referenced with the 10-week-old AT1 and AT2 
cell differential NKX2-1 binding analysis to identify NKX2-1 peaks called only within the 
progenitor. These peaksets were also used to compare between E14.5 and P7 samples. Raw 
signal averages and log2 fold change values were computed on the top 10% or 20% for each 
category over time and between controls and mutants. Binding sites were annotated to genes 
using ChIP-seeker (Yu, Wang et al., 2015). 
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Chapter 3: Nkx2-1 is necessary for the specification, development, and 
maintenance of cell types within alveolar epithelium 
 
[Note: This chapter is based on published material from Little et al 2019 (Little, D. R., et al. 
Transcriptional control of lung alveolar type 1 cell development and maintenance by NK 
Homeobox 2-1, PNAS, doi: https://doi.org/10.1073/pnas.1906663116) PNAS articles are published 
under a CC BY license (Creative Commons Attribution 4.0 International License), which establishes that 
authors retain copyright in their articles.] 
 
3.1 Introduction and rationale 
 Cells often undergo morphological and molecular specialization to fulfill their 
physiological function, such as neurons, cardiomyocytes, and pancreatic beta cells. The cell type 
chiefly responsible for the physiological function of the lung—gas exchange—is the alveolar 
type 1 (AT1) cell. They have expansive morphology, covering multiple alveoli, and fold 
extensively, forming close contacts with the similarly essential vasculature (Morrisey & Hogan, 
2010, Weibel, 1971, Weibel, 2015, Yang & Chen, 2014, Yang et al., 2016). Growing evidence 
indicates that both tissue environment, such as mechanical forces and extracellular matrix, and 
intracellular factors could impact AT1 cell development. For example, reducing mechanical 
tension from fetal breathing by depleting the amniotic fluid or lowering the stiffness of cell 
culture surface favors AT2 over AT1 cell differentiation (Li, Wang et al., 2018). Loss of an 
extracellular matrix protein, COL4A1, also leads to an increased ratio of AT2 to AT1 
cells(Loscertales, Nicolaou et al., 2016). Inside the epithelial cells, beta catenin–mediated 
canonical WNT signaling as well as fibroblast growth factor signaling inhibit AT1 cell 
differentiation (Desai et al., 2014, Frank et al., 2016, Li et al., 2018, Wang, Wang et al., 2016a) 
and HDAC3-dependent TGF-beta signaling is required for proper epithelium expansion and 
AT1 cell spacing (Wang et al., 2016a, Wang, Frank et al., 2016b). More recently, genetic 
analyses of Mst1/2, Lats1/2, and Yap/Taz indicate that Hippo signaling promotes progenitor 
differentiation toward the AT1 cell fate (Lange, Sridharan et al., 2015, Lin, Yao et al., 2015, 
Nantie, Young et al., 2018). This growing list of AT1 cell regulators highlights both the 
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underlying complexity and the necessity to distinguish direct effects on AT1 cells versus those 
on progenitors, AT2 cells, or tissue morphology, especially in light of the classical observation 
of rapid AT1 cell-like differentiation of cultured AT2 cells (Borok, Hami et al., 1995). A better 
understanding of AT1 cell development also requires identification of sequence-specific 
transcription factors that activate AT1 cell-specific genes and cellular machinery that determines 
its unique morphology.  
 In a previous model to disrupt AT1 cell development, we ectopically expressed the 
airway transcription factor SRY-box 2 (SOX2) in developing AT1 cells. These mutant cells 
became airway-like in association with drastic molecular and morphological changes, prompting 
the question of whether they retained the lung fate, which we addressed by immunostaining for 
the lung lineage transcription factor NKX2-1 (Yang et al., 2016). To our surprise, AT1 cells in 
the control lung had nuclear NKX2-1, different from prior reports that NKX2-1 is a lineage 
factor during lung specification and branching morphogenesis, but is lost in AT1 cells upon 
alveolar differentiation (Ikeda, Clark et al., 1995, Liebler et al., 2016). Intriguingly, NKX2-1 
staining in SOX2-expressing mutant AT1 cells was diffuse instead of nuclear, as expected for a 
transcription factor, raising the possibility that NKX2-1 regulates AT1 cell development.  
 In this study, we use precise genetic deletion models and genomic analyses to show that 
NKX2-1 is necessary for the initiation, development, and maintenance of AT1 cells. Nkx2-1 
mutant AT1 cells lose 3 defining features—AT1 cell-specific markers, morphology, and 
quiescence—and aberrantly express gastrointestinal (GI) genes. This study establishes NKX2-1 
as a key transcription factor controlling AT1 cells. 
 
3.2 Results 
3.2.1 NKX2-1 in AT1 cells is required for alveologenesis. 
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 To confirm and extend knowledge of NKX2-1 expression in AT1 cells, we genetically 
marked all lung epithelial cell nuclei, including those of AT1 and AT2 cells, with a ShhCre driver 
(Harfe et al., 2004) and a nuclear Cre reporter, RosaSun1GFP (Heiman et al., 2008). To visualize 
the expansive AT1 cells in their entirety, we used whole mount immunostaining and confocal 
stack imaging of strips cut from lobe edges (ref. 5 and Fig. 2A). In such preparations, AT1 and 
AT2 cells appeared as a “fried egg” and an “egg in the shell,” respectively, as outlined by an 
epithelial junction protein E-cadherin (ECAD) (Fig. 2A). We found that throughout postnatal 
development as well as in the mature lung, NKX2-1 was present in every single green 
fluorescent protein (GFP)-labeled cell, corresponding to both AT1 and AT2 cells, which were 
further distinguished by an AT2 marker, lysosome associated membrane protein 3 (LAMP3) 
(Fig. 2B). Thus, instead of being lost upon AT1 cell differentiation as suggested previously 
(Ikeda et al., 1995, Liebler et al., 2016), NKX2-1 is expressed in both developing and mature 
AT1 cells. 
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Figure 2:  
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Fig. 2. NKX2-1 is required in AT1 cells for alveologenesis  
(A) Schematics of sample preparation to obtain an en face view of complete AT1 cells (traced 
from an immunostained P3 lung), whose conventional sectional view captures part of a cell as a 
line bordering the airspace. (B) Confocal en face view of immunostained RosaSun1GFP/+; ShhCre/+ 
lung strips showing that NKX2-1 is expressed by all epithelial cells, whose nuclei are 
genetically marked with GFP, including all AT1 cells as identified by the expanded cell size 
outlined by ECAD and absence of LAMP3 (arrowheads). At least 2 mice were examined at each 
time point with consistent results. (C) Confocal en face view of immunostained littermate lung 
strips showing specific loss of NKX2-1 in GFP-marked, expanded AT1 cells in the mutant 
(open versus filled arrowheads). At least 3 lungs per genotype were examined with consistent 
results. (D) Left 3 columns: H&E stained sections from littermate lungs. At least 3 lungs per 
genotype were examined with consistent results. Rightmost column: scanning electron 
microscopy images of littermate lungs. (E) Nkx2-1 mutant lungs have an increased mean linear 
intercept (unpaired t test). Each dot represents 1 lung averaged over 5 images. (Scale bars: 10 




 Given the importance of NKX2-1 in early development (Minoo et al., 1995, Minoo et 
al., 1997, Minoo, Su et al., 1999) and its aberrant localization in the SOX2 ectopic expression 
model, as described in the introduction (Yang et al., 2016), we hypothesized that NKX2-1 had a 
role in AT1 cell development. To test this, we generated an AT1 cell-specific knockout of Nkx2-
1 using an Aqp5Cre driver (Flodby et al., 2010, Kusakabe et al., 2006b). A portion of these mice 
had widespread expression of a GFP reporter across organs, possibly due to early recombination 
during embryogenesis or within the parental germline, and were thus excluded from analysis. In 
the remaining mice, Aqp5Cre targeted AT1 cells with an efficiency of 96% and specificity of 
98% within the alveolar epithelium at P5 based on the RosaSun1GFP reporter (n = 3 mice; >1,100 
cells/mouse). Specificity of a cell type-specific driver is defined by the ability of the driver to 
recombine a locus in the desired cell type, often exemplified by assessment of recombination of 
the Rosa locus. In this context, the specificity is calculated within the epithelium where Nkx2-1 
is expressed. Efficiency of a cell type-specific driver is defined by recombination of the Rosa 
locus in all cells within the cell type thought to be targeted by the driver and with specificity, is 
here quantified using ECAD to distinguish NKX2-1 expressing AT1 and AT2 cells based on 
their vastly different cellular morphologies. Recombination driven by Aqp5Cre was also 
observed in occasional non– NKX2-1 expressing, flat cells on the lobe surface, which were 
presumably mesothelial cells. NKX2-1 was lost in 93% of GFP-expressing AT1 cells at P5 (n = 
3 mice, >700 GFP+ cells/mouse) with deletion observed as early as P1 (Fig. 2C). The resulting 
Nkx2-1 mutant mice were visibly smaller starting from P7 and died between P14 and P23. H&E 
staining showed that the mutant lung had enlarged airspaces, thickened septa, and fewer alveoli 
(Fig. 2D). These morphological changes were confirmed with scanning electron microscopy 
(SEM) (Fig. 2D and Fig. 3A). Mean linear intercept, which measures the average alveolar space 
size without distinguishing alveolar ducts, alveolar sacs, and alveoli, was significantly increased 
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in the mutant (Fig. 2E). Thus, loss of NKX2-1 in developing AT1 cells disrupts alveologenesis 






Fig. 3. NKX2-1 in AT1 cells is necessary for alveologenesis, marker expression, and 
proliferation during development 
(A) Scanning electron microscopy images of littermate lungs. (B) Confocal images of 
immunostained sections from littermate lungs showing reduced expression of AT1 markers 
(AQP5 and PDPN) in the mutant (dashed outline) versus controls (filled arrowheads). (C) 
Confocal en face view of immunostained littermate lung strips showing ECAD accumulation at 
cell junctions and reduction of cell perimeter over time in mutant AT1 cells (open versus filled 
arrowheads). (D) Method to quantify KI67 and NKX2-1 with each dot representing the 
respective mean fluorescence intensity of one nucleus. The green dashes and grey arrows 
represent the visual thresholds for KI67 and NKX2-1, respectively. The percentages correspond 
to nuclei above the KI67 threshold. (E) Confocal images of EdU-labeled, immunostained 
littermate lung sections showing EdU labeling in mutant but not control AT1 cells (open versus 
filled arrowheads). (F) Nuclear envelopes, based on Imaris analysis of RosaSun1GFP labeling, 
have a larger surface area in the Nkx2-1 mutant. Each dot represents one nucleus and each 
cluster represents one lung (unpaired t-test). (G) Confocal images of immunostained littermate 
lung sections showing cell death (TUNEL) of occasional mutant AT1 cells. (H) Confocal 
images of immunostained lung sections showing that AT2 cells in mutant lungs are KI67 
negative. All confocal images are representative of at least 3 lungs per genotype. Scale: 20 µm 
in A; 10 µm B, C, E, G, H. 
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3.2.2 NKX2-1 is necessary for 3 defining features of developing AT1 cells. 
 Next, we examined the molecular and cellular changes underlying the described mutant 
phenotypes. Immunostaining of RosaL10GFP (Heiman et al., 2008) lineage-labeled lungs showed 
that Nkx2-1 mutant AT1 cells downregulated 4 AT1 cell markers: homeodomain-only protein 
(HOPX), advanced glycosylation end product-specific receptor (AGER or RAGE), podoplanin 
(PDPN), and aquaporin 5 (AQP5) (Fig. 4A and Fig, 3B). Unlike membrane-localized AT1 
markers, HOPX was present in the nucleus and allowed reliable quantification, which showed 
expression in 28% of GFP+ cells in the mutant lung versus 95% in the control lung at P10 (n = 3 
mice for each genotype; >700 GFP+ cells/mouse). To extend this analysis to all AT1 cell-
specific genes that we compiled from the literature (Flodby et al., 2010, Treutlein, Brownfield et 
al., 2014, Wang, Tang et al., 2018, Yang et al., 2016), we performed RNA-seq of purified 
genetically labeled AT1 cells from P5 control and Nkx2-1 mutant lungs. We found down-
regulation of 25 out of 27 AT1 genes, such as Sema3a, Clic5, Samhd1, Rtkn2, Cav1, Hopx, 
Ager, and Aqp5 (Fig. 4B). Ten out of the 25 down-regulated AT1 genes did not reach statistical 
significance, possibly due to mosaic deletion of Nkx2-1 and/or perdurance because one such 













Fig. 4. NKX2-1 is necessary for AT1 cell gene expression, morphology, and quiescence  
(A) Confocal en face view of immunostained littermate lung strips showing reduced AT1 cell 
markers in GFP-marked AT1 cells in the mutant, including HOPX (open versus filled 
arrowheads) and RAGE (dashed outline). Mutant cell patches are small because mutant cells 
shrink (below) and are outcompeted in size by neighboring control cells. The L10GFP reporter 
is cytosolic and only appears perinuclear because there is a larger amount of cytosol around the 
nucleus of flattened AT1 cells. At least 3 littermate pairs were examined with consistent results. 
(B) Volcano plot of RNA-seq comparison of sorted GFP-marked AT1 cells from 3 pairs of P5 
Nkx2-1CKO/CKO; RosaL10GFP/+; Aqp5Cre/+ mutant and littermate control lungs (paired t test). AT1 
cell genes (cyan) are highlighted in the plot and listed in the order of fold change (all 4 columns; 
top to bottom and then left to right); darker cyan indicates genes below the P = 0.05 line of 
statistical significance. (C) Confocal en face view of immunostained littermate lung strips 
showing a decrease in the cell perimeter of GFP-marked Nkx2-1 mutant AT1 cells, as outlined 
by ECAD (dashes) and as quantified at indicated time points with each dot representing a cell 
from at least 3 lungs per genotype with 5 images per lung (unpaired t test). Open arrowheads 
indicate binuclear (outlined by GFP) mutant AT1 cells. (D) Confocal en face view of 
immunostained littermate lung strips showing KI67 expression in GFP-marked AT1 cells in the 
mutant (open versus filled arrowheads), as quantified at indicated time points with each dot 
representing 1 lung averaged over 3 images (unpaired t test; Top plot). Aberrant proliferation 
was confirmed by EdU staining with each dot representing 1 lung averaged over at least 4 
images (unpaired t test; ns, not significant; Bottom plot). (Scale bars: 10 µm in A, C, and D.) 
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 A second defining feature of AT1 cells is their thin and expansive cell morphology, 
which allows passive gas diffusion (Weibel, 1971). Using the aforementioned whole mount 
immunostaining and imaging method to visualize complete AT1 cells, we found that, while 
control AT1 cells grew over time as reported (Yang et al., 2016), Nkx2-1 mutant AT1 cells were 
smaller as early as P3 and continued to regress until becoming cuboidal at P14, as quantified by 
measuring the cell perimeter (Fig 3C and Fig. 4C). Interestingly, mutant AT1 cells accumulated 
a higher level of ECAD at the cell junctions, possibly as a result of transcriptional up-regulation 
and/or protein redistribution due to cell shrinkage (Fig. 3C). 
 AT1 cells are generally considered quiescent and nonproliferative at baseline, especially 
considering their specialized morphology (Jain et al., 2015, Wang et al., 2018, Yang et al., 
2016). Using the RosaSun1GFP nuclear reporter, we noticed that Nkx2-1 mutant AT1 cells 
frequently exhibited a binuclear mitotic profile (Fig. 3 C and D). To determine if they reentered 
the cell cycle, we examined KI67, a nonquiescent cell marker, and EdU incorporation, an S 
phase readout, at multiple time points. Indeed, we found 30 and 15% of mutant AT1 cells were 
positive for KI67 and EdU, respectively, as compared to negligible percentages for control AT1 
cells (Fig. 3 D and E, Fig. 4D). Notably, proliferating mutant cells were seen as early as P3, 
when cell shrinkage just started and before loss of AT1 markers, suggesting a direct role of 
NKX2-1 in suppressing AT1 cell proliferation. Intriguingly, some mutant AT1 nuclei were also 
larger, as outlined by the nuclear GFP reporter (Fig. 3F). This was perhaps due to a delay in 
mitosis after DNA replication, a possibility consistent with the aforementioned binuclear mitotic 
profile. These proliferating, small mutant AT1 cells formed clusters (Fig. 3C); at P14, 
occasional mutant cells underwent apoptosis based on TUNEL staining (Fig. 3G). No 
compensatory AT2 cell proliferation was observed at an advanced stage of the mutant 
phenotype (Fig. 3H). Collectively, these data suggest that NKX2-1 is required for 3 defining 
features of AT1 cells: cell markers, morphology, and quiescence. Mutant AT1 cell shrinkage 
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Fig. 5. Nkx2-1 deletion leads to cell-autonomous loss of AT1 gene expression, morphology, 
and quiescence during development  
(A) Timeline of tamoxifen (Tam; arrow) injection (0.25 mg) and lung harvest (arrowheads). At 
least 3 littermate pairs were examined at each time point with consistent results. (B) Optical 
sections of en face confocal stacks of immunostained littermate lung strips showing loss of 
NKX2-1 in a subset of GFP-marked AT1 cells (open versus filled arrowheads) in the mutant, 
but none in the control (filled arrowheads). The discrepancy in recombining the Rosa versus 
Nkx2-1 alleles is presumably due to difference in DNA accessibility to the Cre recombinase. 
(Inset) The corresponding AT1 cell nuclei (DAPI). (C) Confocal images of immunostained 
sections from littermate lungs showing reduction of AT1 cell markers (HOPX and RAGE) in a 
subset of GFP-marked AT1 cells in the mutant (open versus filled arrowheads). Neighboring 
control AT1 cells in the mutant lung (filled arrowheads) are unaffected, but can be GFP marked 
as shown in B. (D) Confocal en face view of littermate lung strips showing a decrease in cell 
perimeter of NKX2-1 mutant AT1 cells, as outlined with ECAD (dashes) and as quantified at 
indicated time points with each dot representing a cell from at least 3 lungs per genotype with at 
least 5 images per lung (unpaired t test). (E) Confocal en face view of immunostained littermate 
lung strips showing KI67 expression in GFP-marked NKX2-1 mutant AT1 cells, but not GFP-
marked NKX2-1 expressing control AT1 cells (open versus filled arrowheads). Each dot 
represents 1 lung averaged over at least 3 images (unpaired t test; ns, not significant). Due to 
discrepancy in recombining the Rosa and Nkx2-1 alleles, GFP-marked NKX2-1 expressing AT1 
cells in the mutant lung were quantified separately and served as internal controls. (Scale bar: 10 
µm in B–E.) 
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3.2.3 NKX2-1 regulates AT1 cell development in a cell-autonomous manner. 
 To independently validate the phenotypes and to exclude secondary effects from gross 
structural changes in the Aqp5Cre driven Nkx2-1 deletion model, we used another AT1 cell 
driver, HopxCreER (Jain et al., 2015), which had an efficiency of 11% and specificity of 99% 
within the alveolar epithelium based on the RosamTmG reporter (Muzumdar et al., 2007) in 
neonatal lungs (n = 3 mice; >75 cells/ mouse). We optimized the dose of tamoxifen so that 
NKX2-1 was lost in 38% of GFP-expressing AT1 cells 7 d after tamoxifen injection (n = 3 
mice; >100 GFP+ cells/mouse), resulting in isolated mutant cells and grossly normal lung 
morphology (Fig. 5 A and B). Consistent with the Aqp5Cre deletion model, individual mutant 
AT1 cells lost AT1 cell markers: HOPX, whose expression was detected in 38% of GFP+ cells 
in the mutant lung versus 90% in the control lung (n = 2 mice for each genotype; >50 GFP+ 
cells/mouse), AGER, PDPN, and AQP5, indicating that NKX2-1 is cell-autonomously required 
for AT1 cell gene expression (Fig. 5C and Fig. 6A). The discrepancy between the percentages 
of GFP cells losing NKX2-1 versus HOPX in the mutant was likely due to variations in 
recombination in this limited deletion model. Similarly, mutant AT1 cells underwent cell 
perimeter regression and accumulated ECAD even when surrounded by control AT1 cells (Fig. 
5D). Mutant AT1 cells also proliferated as early as 3 d after Cre activation, as indicated by KI67 
staining (Fig. 5E). We note that although HopxCreER targets occasional AT2 cells, such 
mistargeting cannot account for the high frequency of mutant cells exhibiting the phenotypes. 
Thus, all 3 defining features of developing AT1 cells—cell markers, morphology, and 




























Fig. 6. NKX2-1 mutant AT1 cells have reduced AT1 marker expression and form clusters  
(A, B) Confocal images of immunostained sections from littermate lungs showing reduced 
expression of AQP5 and PDPN in GFP-marked mutant (open arrowheads) versus control (filled 
arrowheads) AT1 cells. (C) Confocal en face view of immunostained littermate lung strips 
showing mutant AT1 cell clusters, as highlighted by ECAD. All images are representative of at 




3.2.4 NKX2-1 is necessary for AT1 cell flattening. 
 By design, both AT1 drivers, Aqp5Cre and HopxCreER, induced recombination after 
commitment to the AT1 cell fate and thus spared the initiation stage of its differentiation (Fig. 
2C). To test if NKX2-1 is required for the first step of AT1 cell differentiation, cell flattening, 
we used Sox9CreER (Soeda et al., 2010) to target the embryonic epithelial progenitors at 
embryonic day (E) 15.5 before their differentiation into AT1 or AT2 cells. NKX2-1 was lost in 
22% of epithelial cells in the mutant lung at E18.5 (n = 2 mice; >1,500 cells/mouse). While 
RosaL10GFP-labeled, recombined cells in the control lung consisted of both flattened AT1 cells 
and cuboidal/columnar AT2/ progenitor cells, none of the Nkx2-1 mutant cells flattened (Fig. 7 
A and B). Nkx2-1 mutant lungs also had decreased expression of an AT1 cell gene PDPN, as 
well as an AT2 cell gene LAMP3, supporting a role of NKX2-1 in both AT1 and AT2 gene 
expression (Fig. 7 C and D). While proliferation was normally low in late gestation lungs, Nkx2-
1 mutant lungs had increased expression of KI67 (Fig. 7E). These data suggest that NKX2-1 is 
















Fig. 7. NKX2-1 is necessary for AT1 cell specification from progenitor cells  
(A) Optical sections of en face confocal images of littermate lung strips. Tam, 2 mg tamoxifen. 
The genotypes apply to C and D. (B) Confocal en face view of immunostained littermate lung 
strips. XZ and YZ-plane optical sections (cyan) illustrate the basal side of the alveolar 
epithelium (yellow) and cell junctions (magenta), as diagrammed. (C, D) Confocal images of 
littermate lung sections showing a reduction in an AT1 cell maker (PDPN) and an AT2 cell 
marker (LAMP3) upon Nkx2-1 deletion (open versus filled arrowheads). (E) Confocal images of 
littermate lung sections showing increased KI67 expression in Nkx2-1 mutant cells (open versus 
filled arrowheads), as quantified at indicated time points with each dot representing one lung 
averaged over 3 images. Control NKX2-1 expressing cells in the mutant lung were quantified 
separately and served as internal controls. All confocal images are representative of two 
littermate pairs. Scale: 10 µm in A, B, C, D, E.  
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3.2.5 NKX2-1 is necessary to maintain AT1 cell fate in the mature lung. 
 To test if NKX2-1 is still required in mature, fully specialized AT1 cells, we deleted 
Nkx2-1 in 5-wk-old mice using HopxCreER, which targeted AT1 cells with an efficiency of 23% 
with a high dose of tamoxifen (6 mg) but had 100% specificity within the alveolar epithelium 
based on the RosamTmG reporter (n = 3 mice; >120 cells/mouse) (Fig. 8 A and B). In this deletion 
model, NKX2-1 was lost in 65% of GFP-expressing AT1 cells (n = 3; >100 GFP+ cells/mouse) 
(Fig. 8B). Mature AT1 cells lost their markers, including HOPX, whose expression was detected 
in 52% of GFP cells in the mutant lung versus 87% in the control lung (n = 2 mice for each 
genotype; >50 GFP+ cells/mouse), AGER, PDPN, and AQP5 (Fig. 6B and Fig. 8C); they also 
regressed in size with accumulated ECAD (Fig. 4D), and reentered the cell cycle as measured 
by KI67 (Fig. 8E). Remarkably, 3 wk after recombination, large clusters of mutant cells were 
observed (Fig. 6C), highlighting the proliferative potential of at least a subset of AT1 cells that 
perhaps arise from AT2 cells during homeostatic turnover in the mature lung (Jain et al., 2015, 
















Fig. 8. NKX2-1 is required to maintain mature AT1 cell gene expression, morphology, and 
quiescence 
(A) Timeline of tamoxifen (Tam; arrows) injection (3 mg) and lung harvest (arrowheads) for 5-
wk-old mice. At least 3 littermate pairs were examined at each time point with consistent 
results. (B) Optical sections of en face confocal stacks of immunostained littermate lung strips 
showing GFP-marked NKX2-1 mutant (open arrowheads) and control (filled arrowheads) AT1 
cells. (Inset) The corresponding AT1 cell nuclei (DAPI). (C) Confocal images of 
immunostained sections from littermate lungs showing reduction of AT1 markers (HOPX and 
RAGE) in a subset of GFP-marked NKX2-1 mutant AT1 cells (open versus filled arrowheads). 
Neighboring NKX2-1 expressing AT1 cells in the mutant lung are unaffected. (D, Top) 
Confocal en face view of immunostained littermate lung strips showing that GFP-marked 
NKX2-1 mutant AT1 cells are smaller (dash). (D, Bottom) Optical sections to show NKX2-1 in 
the corresponding AT1 cell nuclei (DAPI in Insets). Mature AT1 cells are too complex for cell 
perimeter quantification. (E) Confocal en face view of immunostained littermate lung strips 
showing KI67 expression in GFP-marked NKX2-1 mutant AT1 cells, but not GFP-marked 
NKX2-1 expressing control AT1 cells (open versus filled arrowheads). Each dot represents 1 
lung averaged over at least 3 images (unpaired t test). Due to discrepancy in recombining the 
Rosa and Nkx2-1 alleles, GFP-marked NKX2-1 expressing AT1 cells in the mutant lung were 




Fig. 9. NKX2-1 represses gastrointestinal gene expression in AT1 cells during development 
and maintenance  
(A) Volcano plot, as in Fig. 4B, with GI genes highlighted and listed in the order of fold change. 
Red indicates genes below the p=0.05 line of statistical significance. (B) MA plot of RNA-seq 
comparison of whole lungs from P14 littermates with representative AT1 (blue) and GI (orange) 
genes highlighted. (C) Confocal images of immunostained sections from wildtype stomach and 
intestines showing organ-specific expression of TFF2 and PIGR, respectively. (D) Scanning 
electron microscopy (top 2 rows) and transmission electron microscopy (bottom row) of 
littermate lungs showing aberrant apical microvilli-like structures (arrowheads). (E) Confocal 
images of immunostained sections from littermate lungs showing ectopic GI gene expression in 
the mutant during development (top 2 rows) and maintenance (bottom 2 rows). See Fig. 3 and 4 
for experimental timelines. Scale: 10 µm in C, E; 1 µm in D. 
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3.2.6 NKX2-1 represses gastrointestinal gene expression in AT1 cells. 
 In addition to down-regulated AT1 genes, RNA-seq comparison of control and Nkx2-1 
mutant AT1 cells (Fig. 4B) also revealed a group of up-regulated genes that were associated 
with the GI tract (Fig. 9A and Fig. 10A). Similarly, P14 whole lung RNA-seq showed sustained 
expression of GI genes, such as chymotrypsin (Cym), trefoil factor 2 (Tff2), cathepsin E (Ctse), 
hepatic nuclear factor 4A (Hnf4a), V-set and Ig domain containing 1 (Vsig1), and polymeric Ig 
receptor (Pigr) (Fig. 9B and Fig. 10A). Such GI gene up-regulation was confirmed by 
immunostaining, which additionally revealed that mutant cells were heterogeneous, expressing 
all possible combinations of TFF2 and PIGR (Fig. 10B). These heterogeneous cells were 
intermixed, lacking the organ specificity observed in the stomach and intestines (Fig. 9C). 
Notably, close examination using SEM and transmission electron microscopy (TEM) revealed 
that the Nkx2-1 mutant lung epithelium underwent a physical transformation, forming apical 
structures reminiscent of the microvilli of the GI epithelium (Pinson, Dundar et al., 1998) (Fig. 
9D and Fig. 10C). Ectopic expression of GI genes in Nkx2-1 mutant AT1 cells was also 
observed when Nkx2-1 deletion was induced in isolated cells by HopxCreER in both developing 
and mature AT1 cells (Fig. 9E). Collectively, these data suggest that NKX2-1 is cell-










Figure 10:  
 
 
Fig. 10. NKX2-1 represses gastrointestinal gene expression in AT1 cells 
(A) RNA-seq comparison showing up-regulation of GI genes upon Nkx2-1 deletion in both P5 
sorted GFP-marked AT1 cells averaged over 3 littermate lung pairs and P14 whole lungs from 1 
littermate pair. (B) Confocal images of immunostained sections from littermate lungs showing 
ectopic GI markers (PIGR and TFF2) in the alveolar region of the Nkx2-1 mutant lung. Three 
pairs of littermate lungs were examined with consistent results. (C) Scanning electron 
microscopy (Top 2 rows) and transmission electron microscopy (Bottom row) of littermate 
lungs showing aberrant apical microvilli-like structures (arrowheads). (Scale bar: 10 µm in B; 1 
µm in C.) 
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3.2.7 Single-cell RNA-seq reveals transcriptome dynamics upon loss of Nkx2-1. 
 To discern the dynamic NKX2-1–dependent transcriptional changes, we performed 
single-cell RNA-seq (scRNA-seq) of Nkx2-1CKO/CKO; Aqp5Cre/+ mutant and littermate control 
lungs at P10, an intermediate time point when individual AT1 cells in the mutant lung were 
expected to collectively feature the full range of transcriptomic phenotypes (Fig. 10A). We 
developed a cell dissociation and fluorescence-activated cell sorting protocol to purify immune, 
endothelial, epithelial, and mesenchymal cell lineages using CD45, ICAM2, and ECAD 
antibodies (Fig. 11A). Using lungs with all epithelial cells genetically labeled with GFP, we 
verified that the ECAD and EPCAM antibodies were comparable and yielded an epithelial 
fraction with 92% efficiency and 84% specificity (Fig. 11B). We sequenced 2,312 and 2,558 
epithelial cells from control and mutant lungs, respectively, as well as nonepithelial cells that 
were readily identifiable by marker expression but not included in subsequent analyses (Fig. 
11C and Fig. 12A). Epithelial cells, marked by Cdh1 (E-cadherin), consisted mostly of AT1 and 
AT2 cells in the control lung as expected (Fig. 11D), whereas in the mutant lung Nkx2-1 mutant 
AT1 cells, as indicated by loss of Nkx2-1 expression, outnumbered unrecombined AT1 and AT2 
cells presumably as the result of aberrant proliferation (Fig. 4D and Fig 12A). Comparison of 
individual cell transcriptomes with the mouse cell atlas (Han et al., 2018) —which contains 
scRNA-seq data of 400,000 cells from >40 embryonic and adult mouse tissues— confirmed the 
identity of control AT1 and AT2 cells, whereas mutant AT1 cells were similar to fetal intestinal 
epithelial cells (Fig. 11E and Fig. 12A), supporting our bulk RNA-seq and immunostaining 
results (Fig. 9 and Fig. 10). Interestingly, mutant AT1 cells were also transcriptionally similar to 
the principal cells of the fetal kidney collecting duct (Fig. 11E), perhaps reflecting common 
fluid absorption function/genes (e.g., Scnn1b, Scnn1g, and Aqp3) among the lung, intestine, and 
kidney epithelial cells (Chen, Lee et al., 2017), although we cannot exclude the possibility of 
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Fig. 11. scRNA-seq methodology and comparison to the single-cell mouse cell atlas 
(scMCA) 
(A) FACS gating strategy to purify immune (violet), endothelial (teal), mesenchymal (green), 
and epithelial (salmon) cells. The resulting 4 cell lineages were combined so that epithelial cells 
constitute ½ of the cells to be sequenced and the other three cell lineages constitute 1/6 each. (B) 
FACS plots overlaid with GFP from pan-epithelial genetic labeling to show the specificity and 
efficiency of both EPCAM and ECAD antibodies. (C) Seurat tSNE plots from both control and 
mutant lungs using graph-based clustering showing the four color-coded cell lineages based on 
lineage-specific markers (right). Epithelial cells were used in subsequent analyses. The locations 
of epithelial cell clusters are different from those in D due to inclusion of nonepithelial cells, as 
expected. (D) tSNE plots showing the respective epithelial cell types as well as Sox2 and Hnf4a 
expression. (E) Heatmap comparing Nkx2-1 scRNA-seq cells (excluding Mki67 positive cells) 
to all cell types in the mouse cell atlas using Pearson’s correlation (Han et al., 2018).  
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 The nonuniform activation of GI genes (Fig. 9E and Fig. 10B) and prior reports of 
diverse ectopic GI fates (Camolotto et al., 2018, Herriges et al., 2017, Li, Gocheva et al., 2015, 
Maeda, Tsuchiya et al., 2012, Mollaoglu, Jones et al., 2018, Snyder et al., 2013, Tata et al., 
2018) prompted us to construct possible trajectories of the transcriptomic shift upon Nkx2-1 
deletion using Monocle, a program that orders single cells into trajectories based on their 
transcriptomic similarity (Qiu et al., 2017a, Qiu et al., 2017b, Trapnell et al., 2014). We found 
an unbranched linear trajectory connecting control AT1 cells and mutant AT1 cells expressing 
GI genes, suggesting that the observed heterogeneity (Fig. 9E and Fig. 10B) was insufficient to 
support multiple alternative cell fates and perhaps reflected intermediate states that were either 
temporary or permanent during the transition from AT1 to GI fate. The trajectory analysis 
allowed us to stratify the top 1,000 differentially expressed genes into 5 categories based on 
expression dynamics and relationship to the loss of Nkx2-1 expression (Fig. 12 B–E). 
Specifically, early and late downregulated genes included most of the AT1 specific genes (24 
out of 27), such as Rtkn2 and Hopx for the early group and Igfbp2 and Pdpn for the late group. 
The slower decreasing kinetics of the late group could be due to perdurance, as observed for 
Pdpn (Fig. 3B). Early and late up-regulated genes included GI genes, such as GST alpha 1 
(Gsta1) for the early group and Cym for the late group. Activation of the early group occurred 
upon Nkx2-1 loss, possibly representing initiating factors leading to the GI fate, such as Hnf4a 
expression (Fig. 11D and Fig. 12E) (Camolotto et al., 2018, Herriges et al., 2017, Li et al., 2015, 
Maeda et al., 2012, Mollaoglu et al., 2018, Snyder et al., 2013, Tata et al., 2018). However, 
other key transcriptional regulators including Pdx1 and Cdx2 that were activated upon Nkx2-1 
deletion or Sox2 whose ectopic expression drove esophageal differentiation in AT2 and lung 
tumor cells (Herriges et al., 2017, Snyder et al., 2013, Tata et al., 2018) were absent in both up-
regulated groups (Fig. 11D), likely reflecting AT1-specific cell fate plasticity. Interestingly, 
some genes, which included the remaining 3 out of the 27 AT1 genes (i.e., Akap5, Ahnak, and 
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Lmo7), had a biphasic pattern with a high level in the middle of the trajectory, perhaps reflecting 
the net activity of AT1 versus GI-specific regulatory elements of the same gene. Other biphasic 
genes included neutrophil genes, such as Ly6g and S100a8, likely due to a technical artifact of 
cell doublets that were arbitrarily assigned to the middle of the trajectory by Monocle. Taken 
together, NKX2-1 promotes AT1 cell fate; its loss in AT1 cells leads to a linear transition to a 







Fig. 12. Single-cell RNA-seq analysis identifies 5 patterns of differential gene expression 
upon Nkx2-1 deletion  
(A) Seurat t-distributed stochastic neighbor embedding (tSNE) plots of sorted epithelial cells 
from littermate lungs (merged and split views in the 2 Left columns). Most epithelial cells in the 
mutant lung do not express Nkx2-1 (Top in the Rightmost column). Color-coded cell types are 
tabulated and identified using the following markers: control AT1, Aqp5; mutant AT1, Nkx2-1 
negative (early mutant AT1 is closer to control AT1 spatially in the tSNE plot); proliferative, 
Mki67 (B); AT2/AT1, coexpression of Lamp3 and Aqp5; AT2, Lamp3; club, Scgb1a1; and 
ciliated, Foxj1. See Fig. 11D. (B) Representative genes for each pattern of differential gene 
expression. Early up-/downregulated genes exhibit changes in the early mutant AT1 cluster, 
whereas late up-/down-regulated genes exhibit changes in the late mutant AT1 cluster. The 
biphasic genes are first up-regulated and then down-regulated as control AT1 cells transition to 
early and then late mutant AT1 cells. (C) Monocle pseudotemporal analysis of AT1 cells from 
control and mutant lungs, excluding Mki67 positive cells. (D) Pseudotemporal changes of 
representative genes for the 5 patterns of differential gene expression. Vertical dashes demarcate 
loss of Nkx2-1 expression (also in E). (E) Heatmap of pseudotime-dependent gene clusters from 
the top 1,000 differentially expressed genes. Nkx2-1 loss is marked by vertical dashes. A total of 








Fig. 13. NKX2-1 antibody comparison 
(A) Heatmap comparing raw bam files of P10 wildtype lung NKX2-1 ChIP-seq centering on 
peaks for Ab1. (B) NKX2-1 ChIP peaks near known NKX2-1 target genes (Boggaram, 2009, 
Tagne, Gupta et al., 2012). (C) All antibody ChIP data pass the ENCODE standards, including 
cross correlation outputs (left) and irreproducibility discovery rate (IDR) pairwise comparison 
(right). (D) Ab1 and Ab2 IDR peaks are predominantly in the highest-score bin. (E) HOMER de 
novo motif analysis of Ab1 and Ab2 IDR peaks identifies the NKX2-1 binding motif as the top 
hit.  
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3.2.8 NKX2-1 binds near AT1 cell genes in the lung. 
 To determine how DNA binding contributed to NKX2-1–dependent transcriptional 
changes, we performed ChIP-seq in P10 lungs using 4 independent NKX2-1 antibodies. Binding 
was consistent across antibodies throughout the genome including previously characterized 
Nkx2-1 and Sftpb promoters (Fig. 13 A–C). Motif analysis of the resulting DNA binding sites to 
detect enrichment of known transcription factor DNA binding sequences identified the known 
NKX2-1 consensus binding motif as the top hit (Fig. 13E). Further analysis was done using data 
from 2 antibodies: an Abcam antibody (cat. no. 133737) due to its higher protein concentration 
and better performance based on ENCODE standards(Landt et al., 2012) (Fig. 13C) and a 
Millipore antibody (cat. no. 07-601) that was previously used in ChIP experiments (Tagne et al., 
2012). NKX2-1 binding peaks with the highest score represented 62% of all reproducible peaks, 
supporting high data quality, and were mapped using the nearest-gene method to 28% of all 
genes in the mm10 genome, supporting a global transcriptional function of NKX2-1 (Fig. 13D 
and Fig. 14B). When correlated to the 5 expression categories in the trajectory analysis (Fig. 
12E), NKX2-1 binding sites were mapped to 65%, 75%, and 50% of early and late down-
regulated and biphasic genes, respectively, a significant enrichment over the average genome 
(Fig. 14 A and B). Notably, 93% of the 27 AT1 genes had NKX2-1 binding sites, supporting a 
direct and near-universal role of NKX2-1 in promoting AT1 genes. In contrast to this high 
proportion of NKX2-1 binding to AT1 genes, only 41% of early up-regulated genes and 28% of 
late up-regulated genes had NKX2-1 binding sites—a small difference from the average genome 
that disappeared when taking into account the number of peaks for each gene and the number of 









Fig. 14. NKX2-1 binds near AT1 and down-regulated genes  
(A) NKX2-1 ChIP peaks (gray arrows) near genes representative of the 5 patterns of differential 
gene expression (Fig. 12) using wild-type P10 lungs and 2 independent antibodies (Ab1, Abcam 
ab133737; Ab2, Millipore 07-601). (B) Average (per gene) NKX2-1 ChIP peak profiles that are 
color coded as in A and tabulated in the order of peak height. The 27-AT1 gene group has the 
highest average binding. The whole genome (all; 23,793 genes) serves as a reference for 
background binding. Asterisks: P < 0.0001; n.s., not significant (χ2 test). (C) A model 
summarizing the 4 deletion models and showing that Nkx2-1 is required for the specification, 
development, and maintenance of AT1 cells (green). 
  
 75 
3.2.9 NKX2-1 is necessary for AT2 cell development. 
 As a comparison, we also examined the role of NKX2-1 during AT2 cell development 
by deleting it at P4 with SftpcCreER (Rock et al., 2011), which, even at a very low dose of 
tamoxifen (0.5 µg), targeted AT2 cells with an efficiency of 63% and a specificity of 98% 
within the alveolar epithelium, based on the RosaSun1GFP reporter (n = 3 mice; >300 
cells/mouse). We used this limited dose of tamoxifen because a higher amount led to animal 
death within 5 d, presumably due to insufficient surfactant production at a critical stage of lung 
maturation as described below. In this limited deletion model (Fig. 15A), NKX2- 1 was lost in 
5% of GFP-expressing AT2 cells (n = 3 mice; >500 GFP+ cells/mouse) (Fig. 15B). Within 8 d 
of recombination, mutant cells down-regulated AT2 markers including surfactant protein C 
(SFTPC) and LAMP3 (Fig. 15C) and also proliferated and formed clusters, whereas control 
AT2 cells had a much lower level of proliferation at P12 and became nearly quiescent at P18 as 
the lung matured (Fig. 15 C and D). Furthermore, mutant AT2 cells ectopically expressed GI 
genes (Fig. 15E). To fully characterize the mutant AT2 cells and overcome the confounding 
issue of mosaic deletion, we induced recombination with a high dose of tamoxifen (300 µg) and 
sorted GFP+ cells for RNA-seq 3 d later before animal death. We found that mutant cells down-
regulated 23 out of 24 AT2 genes that we compiled from the literature (Beers & Moodley, 2017, 
Treutlein et al., 2014), such as Sftpc, Lamp3, Slc34a2, and Abca3, and up-regulated GI genes, 
such as Tff2, Cym, Ctse, and Hnf4a, confirming our immunostaining results (Fig. 15F). These 
data indicate that NKX2-1 is also required for AT2 cell development but it regulates a set of 









Fig. 15. NKX2-1 is necessary for the development of AT2 cells 
(A) Timeline of tamoxifen (Tam; arrows) injection (0.5 µg) and lung harvest (arrowheads). At 
least 2 littermate pairs were examined at each time point with consistent results. (B) Confocal 
images of immunostained sections of littermate lungs showing NKX2-1 mutant (open 
arrowheads) and control (filled arrowheads) AT2 cells. (C) Confocal images of immunostained 
sections from littermate lungs showing reduction of AT2 markers (SFTPC and LAMP3) in 
mutant AT2 cells (open versus filled arrowheads). (D) Confocal en face view of immunostained 
littermate lung strips showing an increase in KI67 expression in GFP-marked Nkx2-1 mutant 
AT2 cells over control AT2 cells (open versus filled arrowheads). Each dot represents one lung 
averaged over at least 3 images. Due to the discrepancy in recombining the Rosa and Nkx2-1 
alleles, GFP-marked NKX2-1 expressing AT2 cells in the mutant lung were quantified 
separately and served as internal controls. (E) Confocal images of immunostained sections from 
littermate lungs showing ectopic GI markers (PIGR and TFF2) in the alveolar region of the 
Nkx2-1 mutant lung. (F) Volcano plot of RNA-seq comparison of sorted GFP-marked AT2 cells 
from three pairs of P8-P9 Nkx2-1CKO/CKO; RosaSun1GFP/+; SftpcCreER/+ mutant and littermate 
control lungs with recombination induced at P5-P6 with 300 µg tamoxifen (paired t-test). AT2 
cell genes (cyan) are highlighted in the plot and listed in the order of fold change (all 4 columns; 
top to bottom and then left to right); darker cyan indicates genes below the p=0.05 line of 
statistical significance. Gastrointestinal genes are highlighted in orange or red, corresponding to 
genes above or below the p=0.05 line of statistical significance, respectively. (G) A diagram 




In this study, we demonstrate that NKX2-1 is expressed by AT1 cells and is essential at all 
stages of AT1 cells including their specification, development, and maintenance (Fig. 14C). 
This pivotal role of NKX2-1 results from its regulation of 3 defining features of AT1 cells: cell 
type-specific gene expression, morphology, and quiescence. Furthermore, without NKX2-1, 
AT1 cells adopt a GI fate, illustrating remarkable plasticity of an otherwise terminally 
differentiated and highly specialized cell type. Our single-cell and genomic analysis of NKX2-1 
target genes provides a foundation to unravel the transcriptional control of the poorly 
understood AT1 cell. 
 The 3 NKX2-1–dependent features—AT1 cell-specific genes, morphology, and 
quiescence—are likely to be intertwined. On one hand, NKX2-1 binds to a group of AT1 cell-
specific genes, such as Rtkn2, Pmp22, Akap5, and Emp2, that have been implicated in regulating 
the cytoskeleton, membrane composition, and extracellular matrix (Bruggeman, Martinka et al., 
2007, Lee, Park et al., 2016, Lopez-Anido, Poitelon et al., 2016, Rosso, Young et al., 2017, 
Weisenhaus, Allen et al., 2010) and thus could impact the ultrathin, expansive morphology of 
AT1 cells. On the other hand, the complete regression to a columnar shape might be a 
prerequisite to or a result of cell division. However, cell cycle reentry, as based on KI67 
expression, and the binuclear profile are apparent at the beginning of cell shrinkage and before 
complete loss of AT1 cell-specific genes (Fig. 4), suggesting a direct role of NKX2-1 in 
maintaining cellular quiescence. If true, NKX2-1 undergoes a shift from proproliferation during 
early branching morphogenesis (Minoo et al., 1995, Minoo et al., 1997, Tagne et al., 2012), to 
antiproliferation upon AT1 cell differentiation, highlighting the importance of cellular states. 
The transformation of Nkx2-1 mutant AT1 cells to the GI fate is drastic—forming microvilli-
like apical protrusions (Fig. 9D and Fig. 10C) and starting from fully differentiated AT1 cells 
(Fig. 9E). Such transformation is nevertheless incomplete with a transcriptome resembling the 
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fetal, but not mature, intestinal cells (Fig. 11E) and with cells possibly stalled along a linear 
trajectory of cell fate conversion (Fig. 12C), perhaps reflecting a passive drift to an alternative 
endodermal fate in the absence of NKX2-1. Consistent with this idea, NKX2-1 binding to the 
derepressed GI genes is not above the whole genome average, in sharp contrast with the 93% 
binding rate for AT1 genes (Fig. 14B). Similar GI transformation is also reported for Nkx2-1 
mutant AT2 cells and lung tumor cells, possibly as the result of ectopic transcriptional activation 
by FOXA1/2 that are freed from their normal partner NKX2-1 (Camolotto et al., 2018, Snyder 
et al., 2013). However, Nkx2-1 mutant AT1 cells are notably different from mutant AT2 cells in 
that the former do not express Pdx1 nor do they have uniform Hnf4a expression, suggesting that 
cell of origin influences the repertoire of activatable GI genes. Our study paints a fuller picture 
of NKX2-1 function in the lung, including its progenitors and AT1 and AT2 cells, as well as 
other organs, including the thyroid and the brain (Kusakabe, Hoshi et al., 2006a, Kusakabe et 
al., 2006b, Liang, Johansson et al., 2018, Magno, Barry et al., 2017, Magno, Kretz et al., 2011, 
Ostrin, Little et al., 2018, Sandberg, Flandin et al., 2016, Yee, Wang et al., 2009). In each case, 
NKX2-1 promotes a distinct set of cell type-specific genes, emphasizing the importance of 
cellular contexts that may include unique transcriptional cofactors, chromatin states affecting 
NKX2-1 binding or lineage potentials, protein isoforms or modifications such as 
phosphorylation (Kolla, Gonzales et al., 2007, Li, Cai et al., 2000, Silberschmidt, Rodriguez-
Mallon et al., 2011). A thorough comparison of the roles of NKX2-1 in AT1 versus AT2 cells 
using precise genetic models and emerging single-cell genomic and epigenomic tools promises 




Chapter 4: Lung lineage transcription factor NKX2-1 epigenetically 
resolves opposing cell fates in vivo 
 
[Note: This chapter is based on published material that was deposited in bioRxiv, Little et al. 
2020 (Little, D.R, et al. Lung lineage transcription factor NKX2-1 epigenetically resolves 
opposing cell fates in vivo, bioRxiv, doi: https://doi.org/10.1101/2020.09.15.298232) with all 
rights retained by the authors.  
 
4.1 Introduction and Rationale 
 Organism development requires sequential choreographed restriction of progenitors to 
distinct tissue lineages, marked by lineage transcription factors, and subsequently distinct cell 
types within each lineage. This progressive restriction is exemplified by formation of lung, 
pancreas, and hindgut epithelia from the embryonic endoderm, which are marked and controlled 
by NKX2-1, PDX1, and CDX2, respectively, and subsequent further differentiation into distinct 
secretory and absorptive cell types (Habener, Kemp et al., 2005, Morrisey & Hogan, 2010, 
Sherwood, Chen et al., 2009). Unlike lineages of a single cell type such as skeletal muscle cells, 
marked by MYOD (Tapscott, 2005), and melanocytes, marked by MITF (Levy & Fisher, 2011), 
little is known about whether and how lineage transcription factors function distinctly in diverse 
and often opposing cell types within the same lineage. Definition of these differential functions 
is difficult as coexisting cell types in native tissues must be purified to obtain interpretable 
epigenomic data (Adam et al., 2018, Spitz & Furlong, 2012, Trompouki et al., 2011). 
Deciphering such cell type-specific functions of lineage transcription factors will shed light on 
their integration with spatiotemporal inputs of less unique transcription factors to determine cell 
fates during development and regeneration (Adam et al., 2018, Trompouki et al., 2011). 
 The mouse lung alveolar epithelium provides a robust system to study the lineage 
transcription factor NKX2-1, as its constituent cell types can be precisely targeted genetically 
and purified in millions for genomic analyses. Specifically, AT1 and AT2 cells are polar 
opposites in function and morphology with underlying distinct gene expression. AT1 cells are 
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extremely thin yet expansive, allowing passive gas diffusion; whereas AT2 cells are cuboidal 
and secret surfactants to reduce surface tension1. Nevertheless, both cell types arise from 
embryonic SOX9 progenitors, and thus their opposing cell fates must be resolved during 
development and their identities guarded afterwards, especially given that AT2 cells are able to 
differentiate into AT1 cells during injury-repair (Barkauskas et al., 2013, Desai et al., 2014). 
Both AT1 and AT2 cells express NKX2-1 and whole lung ChIP-seq shows that NKX2-1 binds 
to both AT1 and AT2-specific genes (Little et al., 2019). However, cell type-specific deletion 
experiments demonstrate that NKX2-1 is cell-autonomously required for AT1 and AT2 cell 
differentiation, raising the question of how the same lineage transcription factor regulates cell 
type-specific genes in each cell type. 
 Conceptually, NKX2-1 and transcription factors in general recognize short DNA 
sequences, known as motifs, which occur too frequently in the mammalian genome to be 
informative on their own, thereby also limiting the utility of in vitro and even in vivo reporter 
assays as well as overexpression models (Spitz & Furlong, 2012). Additional specificity arises 
from neighboring sequences that are bound by partner transcription factors and from differential 
chromatin accessibility regulated by pioneer factors and chromatin remodelers (Zaret, 2020, 
Zovkic, 2020). Furthermore, transcription factor binding does not necessarily result in 
transcriptional changes in nearby genes, reflecting instead primed/poised enhancers, shadow 
enhancers, or simply opportunistic binding (Buffry, Mendes et al., 2016, John, Sabo et al., 2011, 
Spitz & Furlong, 2012). The relevance of these modes of action to a given transcription factor 
ideally needs to be defined in native tissues, and using purified cell populations, since DNA 
binding and epigenetic features differ widely across cell types. 
 In this study, using both bulk and single-cell transcriptomic and epigenomic analyses of 
purified native cells, we mapped NKX2-1 binding in AT1 versus AT2 cells, as well as their 
embryonic progenitors. We defined the effect of NKX2-1 binding on chromatin accessibility 
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using cell type-specific Nkx2-1 mutants. We show that in native tissues, the lineage transcription 
factor NKX2-1 resolves opposite cell fates and exerts its cell type-specific function via 
differential binding in part under the control of YAP/TAZ transcriptional cofactors, and that 
NKX2-1 binding regulates a cell type-specific epigenetic landscape that is not predicted by the 
transcriptome, providing insights into cell fate determination during lung development and 
injury-repair. 
 
4.2 Results  
4.2.1 NKX2-1 binds chromatin in a cell type-specific manner  
 The cell type-specific functions of a transcription factor – in this case, NKX2-1 in AT1 
versus AT2 cell differentiation – can be attributed to differential chromatin binding or equal 
binding but differential transcriptional activity. NKX2-1 ChIP-seq experiments using whole 
lungs have demonstrated the ability of NKX2-1 to bind to both AT1 and AT2-specific genes but 
could not determine differential functions of NKX2-1 in these cells types (Little et al., 2019). 
Therefore, we adopted a cell type-specific epigenomic method (Mo et al., 2015). We performed 
ChIP-seq for NKX2-1 and various histone marks using purified GFP-expressing nuclei that 
were genetically labeled by either a newly characterized AT1-specific driver Wnt3aCre (Yoshida 
et al., 2006) or a AT2-specific driver SftpcCreER (Chapman et al., 2011) The Wnt3aCre (Yoshida 
et al., 2006) driver exhibited recombination of the Rosa locus resulting in GFP expression in 
76% of all AT1 cells known as efficiency and 100% specificity targeting only AT1 cells within 
the epithelium of 10-week-old lungs based on 4,215 GFP+ cells from 3 mice. AT1 and AT2 
cells were distinguished by vastly different cellular morphologies using ECAD colocalized with 
expression of NKX2-1. In 2 mice at P7, Wnt3aCre  driver exhibited 62% efficiency and 99.3% 
specificity based on 2,096 GFP+ cells. The AT2-specific driver SftpcCreER (Chapman et al., 
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2011) exhibited 92% efficiency and 99.8% specificity within the epithelium of 10-week-old 
lungs based on 1,698 GFP+ cells from 3 mice, and 97% efficiency and 96% specificity at P7 
based on 2,096 GFP+ cells from 3 mice) (Fig. 16a and Fig. 18a). Comparison of H3K4me3 
locations, a marker of active promoters (Santos-Rosa, Schneider et al., 2002), in purified AT1 or 
AT2 nuclei data from the whole lung validated the expected enrichment or depletion of 
H3K4me3 near an AT1 (Spock2) or AT2 (Lamp3) specific gene, a generic epithelial gene 





Fig. 16. Additional validation of the Wnt3aCre and SftpcCreER drivers 
(a) Genetic labeling and FACS purification of AT1 and AT2 nuclei at P7 using Wnt3aCre and 
SftpcCreER, respectively. The non-AT1 cells targeted by Wnt3aCre were mostly immune cells 
(3.3% of GFP cells), which did not express NKX2-1, and occasional AT2 cells (0.7% of GFP 
cells). Confocal images of immunostained lungs showing that all alveolar cells express NKX2-1 
while AT2 cells are marked by LAMP3 and cuboidal E-Cadherin (ECAD) outline. RosaSun1GFP 
marks the nuclear envelop of recombined cells (arrowheads; green in the diagram). All nuclei 
are Sytox Blue positive. For SftpcCreER, 250 µg tamoxifen was administrated 3 days before tissue 
harvest. Scale: 10 µm. (b) Confocal images of immunostained lungs showing labeling of 
immune cells (CD45) by Wnt3aCre, which do not express NKX2-1 and thus do not interfere with 
NKX2-1 ChIP-seq. Scale: 10 µm. 
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 NKX2-1 ChIP-seq using purified AT1 and AT2 nuclei from adult lungs revealed three 
categories of NKX2-1 sites: AT1-specific, AT2-specific, and common to both (Fig. 18c). Cell 
type-specific NKX2-1 sites were often near corresponding cell type-specific genes and 
associated with enrichment of H3K4me3 (active promoter) and H3K27ac and H3K4me1 
(putative enhancer), as exemplified by an AT1-specific (Spock2) or AT2-specific (Lamp3) gene 
(Fig. 18 c and d). The majority of cell type-specific NKX2-1 sites were distal regulatory 
elements (>2 kb from the nearest defined transcription start site; 92% and 89% for AT1-specific 
and AT2-specific sites, respectively), as also reflected in the enrichment of H3K27ac signals 





Fig. 17. scATAC-seq deconvolves NKX2-1 ChIP-seq binding into lineage and 
housekeeping peaksets 
(a) ScATAC-seq UMAPs of indicated cell types (abbreviation in parenthesis for the dot plot) 
and lineages (abbreviation in parenthesis for b, c), as supported by the corresponding markers in 
the dot plot. (b) NKX2-1 ChIP-seq heatmaps grouped by differential NKX2-1 binding as in Fig. 
1 and cross-referenced to scATAC-seq heatmaps from a. Cell type-specific NKX2-1 binding 
sites have higher scATAC-seq signals in the corresponding cell type; NKX2-1 lineage sites have 
higher scATAC-seq signals in the epithelial cell types; whereas NKX2-1 housekeeping sites 
have comparable scATAC-seq signals across lineages. NKX2-1 lineage sites are sorted by 
scATAC-seq signals in Sox2 airway cells to show a subset (bottom) with less chromatin 
accessibility in airway cells than alveolar cells. (c) Example NKX2-1 binding sites and 
scATAC-seq signals of the AT1-specific (Spock2), AT2-specific (Lamp3), lineage (Cdh1), and 
housekeeping (Gapdh) sets. 
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 We posited that the common NKX2-1 bound sites were associated with characteristics 
shared between AT1 and AT2 cells and thus could include lung epithelial lineage or those 
accessible in nearly all cell types, which we termed housekeeping sites by analogy to 
housekeeping genes. To define and deconvolve these lineage and housekeeping sites, we 
performed single-cell ATAC-seq (scATAC-seq) on adult lung cells of the four lineages – 
epithelial, endothelial, immune, and mesenchymal – that were purified and combined in equal 
proportions to adequately sample multiple cell types within each lineage as described (Cain, 
Hernandez et al., 2020) (Fig. 17a). Of the NKX2-1 binding sites common between AT1 and 
AT2 cells, 5,862 peaks had higher chromatin accessibility in the epithelial lineage and were 
considered lineage sites, as exemplified by Cdh1, whereas the remaining 20,881 peaks were 
accessible in all four lineages and were considered housekeeping sites, as exemplified by Gapdh 
(Fig. 17 b, c amd Fig. 18 c, d). A subset of the lineage sites (2,221 peaks) had lower chromatin 
accessibility in SOX2-expressing airway cells, likely reflecting the distinct anatomic location 
and developmental history of alveolar versus airway cells (Yang & Chen, 2014) (Fig. 17b). 
 Like the cell type-specific sites, NKX2-1 lineage-specific sites were mostly distal to 
promoters (91.9%), whereas the housekeeping sites were often found near promoters (42%), and 
these locations were consistent with the distributions of with the histone modifications (Fig. 
18c). Notably, 21% of the housekeeping sites were depleted for all three histones marks (Fig. 
18c) and were associated with a 36-fold (60% over 1.7% background) enrichment for the CTCF 
motif, indicative of chromatin insulators (Hnisz, Day et al., 2016), in addition to the expected 
NKX motif (62% over 34% background), implicating NKX2-1 in higher order chromatin 
organization. Together, these data delineate the common and distinct binding profiles of NKX2-







Fig. 18. NKX2-1 binds chromatin in a cell type-specific manner  
(a) Genetic labeling and FACS purification of AT1 and AT2 nuclei using Wnt3aCre and 
SftpcCreER, respectively. Confocal images of immunostained lungs showing that both AT1 and 
AT2 cells express NKX2-1 while AT2 cells are distinguishable by LAMP3 and cuboidal E-
Cadherin (ECAD). RosaSun1GFP marks the nuclear envelop of recombined cells (arrowhead; 
green in the diagram). The non-AT1 cells targeted by Wnt3aCre are mostly immune cells that 
accumulate over time to range from 3.3% of GFP cells at P7 (Fig. 16b) to 30% at 10-weekold, 
but do not express NKX2-1. All nuclei are Sytox Blue positive. 10-wk: 10-week-old. For 
SftpcCreER, 3 mg tamoxifen was administrated 3 days before tissue harvest. Scale: 10 µm. The 
color scheme (AT1: green; AT2: purple) is kept in subsequent figures. Images are representative 
of at least three biological replicates (same in subsequent figures). (b) Validation of cell type-
specific ChIP-seq using an active promoter marker H3K4me3. Compared to the whole lung, the 
site (asterisk; same in subsequent figures) near an AT1 gene Spock2 shows enrichment in 
purified AT1 nuclei but depletion in purified AT2 nuclei, whereas the site near an AT2 gene 
Lamp3 shows the opposite pattern. A pan-epithelial gene Cdh1 (also known as E-Cadherin) is 
enriched in both AT1 and AT2 nuclei, whereas a mesenchymal gene Pdgfra is depleted in both. 
P, postnatal day. For SftpcCreER, 250 µg tamoxifen was administrated days before tissue harvest. 
(c) ChIP-seq heatmaps (2.5 kb flanking the peak center; same in subsequent figures) of purified 
AT1 and AT2 nuclei for NKX2-1, H3K4me3 (active promoter), H3K27ac (putative active 
enhancer; note its bimodal pattern surrounding the center), and H3K4me1 (putative enhancer 
and active gene body), grouped by differential NKX2-1 binding into AT1-specific, AT2-
specific, and common peaksets (number of sites shown in parenthesis; same in subsequent 
figures) and sorted by the H3K4me3 signal. The common peakset is divided into lineage 
(epithelial) and housekeeping sets, based on scATAC-seq (Fig. 17). Compared to the cell type-
specific and lineage sets, the housekeeping set has abundant H3K4me3, which also corresponds 
to depletion of H3K4me1 (top portion), whereas the bottom portion (curly bracket) is depleted 
of H3K4me3 and is enriched for the insulator CTCF motif. d, Example NKX2-1 binding sites of 




4.2.2 NKX2-1 is required for chromatin accessibility at cell type-specific sites  
 To test the functionality of the identified NKX2-1 binding, we examined changes in 
chromatin accessibility 5 days after AT1 or AT2-specific Nkx2-1 deletion in the adult lung using 
a newly generated driver under the control of an AT1-specific gene Rtkn2CreER (95% efficiency 
and 98% specificity based on 1,356 GFP cells from 3 mice; Fig. 19 a and b) or SftpcCreER (95% 
efficiency and 99.8% specificity based on 4,215 GFP+ cells from 3 mice), respectively. In the 
resulting Nkx2-1CKO/CKO; RosaSun1GFP/+; Rtkn2CreER/+ mutant (abbreviated as NKX2-1Rtkn2). 
NKX2-1 was lost in 86% of recombined GFP-expressing cells at 5 days after recombination 
(based on 1,339 GFP+ cells from 3 mice) and 99% at 7 days after recombination (based on 
1,011 GFP+ cells from 3 mice) (Fig. 20a). An AT1-specific marker HOPX was lost, and a 
proliferation marker KI67 was ectopically expressed in occasional cells 5 days after 
recombination but in 51% of GFP+ cells 7 days after recombination (Fig. 19c and Fig. 20a). 
Similarly, in the Nkx2-1CKO/CKO; RosaSun1GFP/+; SftpcCreER/+ mutant (abbreviated as NKX2-1Sftpc), 
NKX2-1 (82% of 6570 GFP cells from 3 mice) and SFTPC were lost while KI67 was 
ectopically expressed 5 days after recombination (34% of 6,570 GFP+ cells from 3 mice) (Fig. 





Fig. 19. Generation of Rtkn2CreER mice and proliferation in Nkx2-1 mutants 
(a) CRISPR (clustered regularly interspaced short palindromic repeats) targeting of the Rtkn2 
locus. The gRNA sequence is shown with the protospacer adjacent motif (PAM) underlined; the 
translation start of Rtkn2 (ATG in red) is replaced by that of CreER. Locus-specific PCR 
genotyping identifies a positive founder mouse. (b) Confocal images of immunostained lungs 
showing Rtkn2CreER does not target immune (CD45) or endothelial (ERG) cells. Two doses (1.5 
mg) of tamoxifen (Tam) were administered for the first panel and one dose (2 mg) for the 
second panel. Scale: 10 µm. (c, d) Confocal images of immunostained lungs of NKX2-1Rtkn2 (c) 
and NKX2-1Sftpc (d) mutants and their littermate controls, as in Fig. 20, showing ectopic 
proliferative (KI67) cells 7 and 5 days after tamoxifen (Tam) administration, respectively. 
Proliferation is rare 5 days after tamoxifen in the NKX2-1Rtkn2 mutant. Scale: 10 µm. 
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 Bulk ATAC-seq comparison of purified GFP-expressing AT1 cells from the NKX2-
1Rtkn2 mutant and littermate control lungs showed an obvious reduction in chromatin 
accessibility at AT1-specific NKX2-1 binding sites and lineage sites, but limited changes at 
AT2-specific and housekeeping sites (Fig. 20 c and d). Conversely, purified AT2 cells from the 
NKX2-1Sftpc mutant lost chromatin accessibility at AT2-specific NKX2-1 binding sites and 
lineage sites, but not AT1-specific and housekeeping sites (Fig. 20c and d). We noted that 
mutant AT1 cells had a larger decrease in chromatin accessibility than mutant AT2 cells at 
lineage sites such as Cdh1 – perhaps reflecting differential sensitivity of some genes to loss of 
NKX2-1 (Fig. 20d). Sftpb, an AT2 gene, had both AT2-specific and lineage NKX2-1 sites that 
depended on NKX2-1 in the expected manner (Fig. 20d), suggesting combinatorial control by 
multiple regulatory elements. Notwithstanding gene-specific differences, chromatin accessibility 
at cell type-specific NKX2-1 peaksets in both AT1 and AT2 cells depends upon NKX2-1, 






Fig. 20. NKX2-1 is required for chromatin accessibility at cell type-specific sites  
(a, b) AT1-specific a and AT2-specific b deletion of Nkx2-1 using Rtkn2CreER and SftpcCreER, 
respectively. Confocal images of immunostained mature lungs, showing efficient loss (filled 
versus open arrowhead) of NKX2-1 in recombined cells marked by GFP (a and b), as well as an 
AT1 marker (HOPX in a) and AT2 markers (LAMP3 and SFTPC in b). Note the increased 
ECAD staining in the AT1-specific Nkx2-1 mutant a, consistent with our publication (Little et 
al., 2019). Two doses (3 mg each; 48 hr interval) of tamoxifen (Tam) were given and the lungs 
were harvested at 5 or 7 days after the initial dose. Scale: 10 µm. (c) ATAC-seq heatmaps of 
purified AT1 cells from AT1-specific Nkx2-1 mutant (as in a; abbreviated as NKX2-1Rtkn2) and 
littermate control (AT1 C) lungs, and purified AT2 cells from AT2-specific Nkx2-1 mutant (as 
in b; abbreviated as NKX2-1Sftpc) and littermate control (AT2 C) lungs, at the same NKX2-1 
ChIP-seq peaksets organized as in Fig. 1. Both mutants are from mature lungs at 5 days after the 
initial tamoxifen administration as in a. AT1-specific and AT2-specific NKX2-1 peaksets have 
reduced chromatin accessibility in the corresponding cell type and cell type-specific mutants; 
the lineage peakset has reduced chromatin accessibility in both mutants; whereas the 
housekeeping peakset is largely unaffected. (d) Example chromatin accessibility signals at 
NKX2-1 binding sites of the AT1-specific (Spock2), AT2-specific (Lamp3), lineage (Cdh1), and 
housekeeping (Gapdh) sets. Chromatin accessibility at sites near Cdh1 in AT2 cells is 
unaffected by Nkx2-1 deletion, possibly due to AT2-specific redundant mechanisms to maintain 
chromatin accessibility. An NKX2-1-bound lineage site ~30 kb upstream of Sftpb (black 
asterisk) has reduced chromatin accessibility in both Nkx2-1 mutants. Sftpb also has an AT2-
specific NKX2-1 site at its promoter (purple asterisk) that has reduced chromatin accessibility 
specifically in the NKX2-1Sftpc mutant. 
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4.2.3 NKX2-1 establishes cell type-specific binding via selectively acquiring de novo sites and 
retaining sites bound in progenitors 
 Next, we sought to determine the kinetics of establishing AT1 and AT2-specific NKX2-
1 binding sites as AT1 and AT2 cells differentiate from their SOX9-expressing progenitors 
(Yang & Chen, 2014). We chose to profile SOX9 progenitors at E14.5 when no appreciable 
AT1 versus AT2 differentiation was detectible by single-cell RNA-Seq (scRNA-seq) (Gerner-
Mauro, Akiyama et al., 2020). Although we used E14.5 whole lungs, instead of purified cells, to 
obtain enough tissue, NKX2-1 was not present in non-epithelial cells and SOX9 progenitors 
constituted the majority (70%) of epithelial cells (Gerner-Mauro et al., 2020). Since AT1 cells 
continued to grow after birth (Yang et al., 2016), we additionally profiled purified AT1 and AT2 
cells at P7 to capture their intermediate epigenetic states using Wnt3aCre and SftpcCreER, 
respectively. 
 We found that NKX2-1 binding sites that were differential in the adult AT1 versus AT2 
cells could range from absent to abundant in the progenitors. The 20% of cell type –specific 
NKX2-1 sites with low NKX2-1 binding in progenitors showed a gradual increase in NKX2-1 
binding over time in the expected cell type with little increase in the alternative cell type. We 
refer to these sites as acquired sites. In contrast, the 20% of cell type-specific NKX2-1 sites with 
high levels of NKX2-1 binding in progenitors maintained NKX2-1 binding in the expected cell 
type but showed a gradual loss in the alternative cell type, which we named retained sites (Fig. 
21 a and b). Therefore, as additionally exemplified by Pdpn and Hopx for AT1-specific sites and 
Sftpb and Lamp3 for AT2-specific sites (Fig. 21 c and d), cell type-specific NKX2-1 binding is 
achieved via selectively acquiring sites de novo as well as by retaining sites already bound in 
progenitors. Quantification of such kinetics confirmed the gradual increase or decrease in 
binding over time (Fig. 21 a and e) and also suggested that the binary on/off binding in 
 96 
individual cells is graduated on a population level, likely due to asynchrony across cells/genes 
and/or varied duration in binding within a cell, providing a possible molecular explanation for 




Fig. 21. NKX2-1 establishes cell type-specific binding via selectively acquiring de novo sites 
and retaining sites bound in progenitors 
(a, b) NKX2-1 ChIP-seq heatmaps from E14.5 whole lungs, purified AT1 or AT2 nuclei from 
P7 or 10-week-old lungs, grouped by differential NKX2-1 binding in 10-week-old AT1 versus 
AT2 cells into AT1-specific a and AT2-specific b peaksets and sorted by differential NKX2-1 
binding between E14.5 lungs and 10-week-old AT1 a or AT2 b cells. The top (acquired) and 
bottom (retained) 20% sites (boxed area) are averaged for the profile plots (dash represents the 
biological replicate) and the corresponding log2 fold changes from the E14.5 lungs. Acquired 
AT1-specific sites have little binding in progenitors, and increase over time in AT1 but not AT2 
cells; whereas retained AT1-specific sites have high binding in progenitors, and remain high in 
AT1 but not AT2 cells a. The same kinetics applies to AT2-specific sites b. The small different 
in the number of peaks from Fig. 1 is due to incorporation of E14.5 and P7 NKX2-1 ChIP-seq 
data. (c, d) Example NKX2-1 binding sites of acquired (Pdpn) or retained (Hopx) AT1-specific 
sets c and acquired (Sftpb) or retained (Lamp3) AT2-specific sets d. (e) NKX2-1 binding signal 
of the indicated four categories in a and b, showing the kinetics leading to differential binding at 




 Unlike cell type-specific NKX2-1 sites of which a comparable number were acquired 
and retained, sites common to AT1 and AT2 cells were mostly retained, as exemplified by Irf2, 
consistent with them being lineage and housekeeping sites (Fig. 22 a-c). Our kinetics analysis 
also revealed 6,933 progenitor-specific NKX2-1 binding sites that decreased quickly or slowly, 
but similarly along the paths of AT1 versus AT2 differentiation, as exemplified by Tinag (Fig. 
22 a-c). 
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Fig. 22. Additional temporal analysis of NKX2-1 binding 
(a) NKX2-1 ChIP-seq heatmaps from E14.5 whole lungs, purified AT1 or AT2 nuclei from P7 
or 10-week-old lungs, grouped as common (top) or progenitor-specific (bottom) peaksets and 
sorted by differential NKX2-1 binding between E14.5 lungs and the average of 10-week-old 
AT1 and AT2 cells. As in Fig. 3 and 4, the top (acquired or lost) and bottom (retained or 
reduced) 20% sites (boxed area) are used for subsequent analysis. The acquired common sites 
have little binding in progenitors and increase over time in both AT1 and AT2 cells, while the 
retained common sites have comparable binding in progenitor, AT1, and AT2 cells. The lost or 
reduced progenitor-specific sites have high binding in progenitors but decrease drastically or to 
a lesser extent, respectively, over time in both AT1 and AT2 cells. (b) Example NKX2-1 
binding sites (asterisk) of acquired or retained common sites (Irf2; both types near the same 
gene) and lost or reduced sites (Tinag). (c) NKX2-1 binding signal of the indicated four 
categories in a, showing the kinetics of common and progenitor-specific sites as AT1 (left) 
versus AT2 (right) cells mature. (d) ScRNA-seq feature plots validating progenitor (Sox9), AT1 
(Spock2, Pdpn, and Hopx), and AT2 (Sftpb and Lamp3) cells in Fig. 4a. (e) Seurat module 
scores of gene sets associated with acquired or retained common NKX2-1 sites and lost or 
reduced progenitor-specific sites as defined in a, plotted along the Monocle trajectories as in 
Fig. 23. (f) NKX2-1 binding signal of the four categories as in e in AT1 or AT2 cells over time, 
using data from c. Acquired common sites are associated with an increase in the module score 
over time, albeit more gradually in AT1 cells, while retained common sites have relatively 
constant module scores. Neither lost nor reduced progenitor-specific sites are associated with a 




4.2.4 Acquired and retained NKX2-1 sites have comparable kinetics in transcriptional 
divergence of progenitors toward opposing cell fates 
 The two modes of achieving differential binding – acquiring de novo sites versus 
retaining bound sites – prompted us to examine if these modes were associated with distinct 
kinetics of transcription. We compiled 12 scRNA-seq datasets from E14.5 to 15-week-old lungs 
that included 23,577 epithelial cells (Fig. 22d and Fig. 23a). AT1 and AT2 cells were 
readily distinguishable at E18.5 but clustered separately from their postnatal counterparts, 
perhaps due to transcriptional changes upon exposure to air and airborne factors (Fig. 23a). 
Monocle analysis showed a bifurcated trajectory originating from embryonic SOX9 progenitors 
and splitting toward adult AT1 and AT2 cells, as respectively exemplified by Sox9, Spock2, and 
Lamp3 (Fig. 23 b and c). 
 To buffer the known uncertainty in attributing regulatory elements to target genes 
(Hollbacher, Balazs et al., 2020), we assigned all acquired or retained cell type-specific sites to 
their nearest gene and generated an expression score averaging over all genes within a set 
(>1,000 genes). The resulting module score for the acquired sites was low in SOX9 progenitors 
and increased along the trajectory toward the expected cell type, but remained low in the 
alternative cell type (Fig. 23 d and e). Surprisingly, the module score for the retained sites had 
essentially the same kinetics, despite a high level of NKX2-1 binding in SOX9 progenitors (Fig. 
23 d and e). By comparison, acquired or retained sites that were common to AT1 and AT2 cells 
had a score that increased or did not change, respectively, along both AT1 and AT2 cell 
trajectories (Fig. 22 e and f). Module scores for progenitor-specific NKX2-1 sites did not 
change, perhaps due to exclusion of proliferating cells from our Monocle analysis (Fig. 22 e and 
f). The remarkable dissociation between NKX2-1 binding and gene expression for the retained 
cell type-specific sites (Fig. 23 d and e) suggested that the epigenome of the progenitors is 
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earmarked by NKX2-1 for future transcription of cell type-specific genes, providing epigenetic 
evidence for SOX9 progenitors being bipotential progenitors for AT1 and AT2 cells (Desai et 




Fig. 23. Acquired and retained NKX2-1 sites have comparable kinetics in transcriptional 
divergence of progenitors toward opposing cell fates  
(a) ScRNA-seq UMAPs (Uniform Manifold Approximation and Projection) of color-coded 
E14.5 to 15-week-old lungs identify the indicated cell types and numbers in the alveolar region 
and show the gradual transcriptomic shifts of AT1 and AT2 cells from SOX9 progenitors, as 
supported by the dot plot for AT1 (Spock2), AT2 (Lamp3), progenitor (Sox9), and proliferative 
(Mki67) cells. (b) Monocle trajectory analysis of cells in a excluding proliferative AT2 cells, 
showing 3 branches (circled number) consistent with SOX9 progenitors differentiating into AT1 
or AT2 cells, as supported by expression of the respective markers Sox9, Spock2, and Lamp3. 
(c) The same Monocle trajectory in c split by sample time points and colored as in a. E14.5 and 
E16.5 cells are largely homogeneous and limited to branch 1 (progenitor branch). (d) Seurat 
module scores of gene sets associated with acquired or retained AT1 or AT2-specific NKX2-1 
sites as defined in Fig. 3, plotted along the Monocle trajectories as numbered in c. (e) NKX2-1 
binding signal of the four categories as in d in the AT1 or AT2 cell over time, using data from 





4.2.5 AT1-specific partner factors YAP/TAZ establish AT1-specific NKX2-1 binding and cell 
fate, and antagonize those of AT2 cells 
The functional, differential NKX2-1 binding in AT1 versus AT2 cells led us to pursue 
the hypothesis that cell type-specific NKX2-1 binding was guided by partner transcription 
factors, which should be cell type-specific and have their binding sites near those of NKX2-1. 
Accordingly, we performed a motif analysis of AT1-specific, AT2-specific, and 
common NKX2-1 sites (Fig. 25a) and found the expected NKX motif in all three categories 
(54% over 25% background, 58% over 22% background, and 52% over 27% background, 
respectively). Intriguingly, the second most enriched motif was TEAD for AT1-specific sites 
and CEBP for AT2-specific sites, whereas the common sites contained motifs for FOXA, likely 
corresponding to the endoderm regulators FOXA1/A2 (Ang, Wierda et al., 1993), as well as 
CTCF, an insulator factor as described earlier (Fig. 25a). To pinpoint the specific members of 
the TEAD motif family, we used our scRNA-seq dataset and found that Tead1/4 were enriched 
in AT1 cells (Fig. 24a). Anticipating the complex genetics required to dissect possible 
redundancy among the four TEAD homologs, we focused on their obligatory Hippo signaling 
cofactors, YAP/TAZ, because the canonical target genes, Ctgf and Cyr61 (Zheng & Pan, 2019), 
were specific to AT1 cells (Fig. 24a). Indeed, active nuclear YAP/TAZ were specifically 
detected in developing and mature AT1 cells (Fig. 25b). Similarly, CEBPA was specific to AT2 
cells on both transcriptional and protein levels (Fig. 24a and Fig. 25b). 
 To test if YAP/TAZ/TEAD functioned as partner transcription factors for NKX2-1, we 
deleted Yap/Taz from SOX9 progenitors using our previously characterized Sox9CreER (Little et 
al., 2019, Ostrin et al., 2018) at E15.5 when AT1 and AT2 cell differentiation just started, and 
performed NKX2-1 ChIP-seq on E18.5 control and Yap/Taz mutant (abbreviated as Y/TSox9) 
whole lungs (Fig. 25 c and d). As we hypothesized, 5,877 sites with decreased NKX2-1 binding 
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corresponded to AT1-specific NKX2-1 sites in the adult lung, as exemplified by sites near 
Spock2 and Hopx (Fig. 25d and e). Interestingly, 5,276 sites had an increase in NKX2-1 binding 
in the Y/TSox9 mutant and corresponded to AT2-specific NKX2-1 sites, as exemplified by sites 
near Lamp3 and Cebpa (Fig. 25d and e). Therefore, YAP/TAZ and by extension TEADs direct 
NKX2-1 to its AT1-specific sites and prevent its binding to AT2-specific sites, at least on the 
population level. 
 To determine the transcriptomic consequence of such a shift in NKX2-1 binding and to 
provide resolution on the level of individual cells, we performed scRNA-seq on E18.5 Y/TSox9 
mutant and littermate control lungs. The Y/TSox9 mutant lung had many fewer AT1 cells 
accompanied by a large increase in AT2 cells (Fig. 25f); the remaining AT1 cells upregulated a 
subset of AT2 genes, such as Sftpc and Lamp3, compared to their counterparts in the control 
lung (Fig. 25g). Control AT2 cells at E18.5 expressed a low level of AT1 genes, such as Hopx 
and Ager, likely due to perdurance from SOX9 progenitors during their initial differentiation 
toward AT1 cells and/or incomplete silencing of AT1 genes as a feature of future stem cells. 
Such remnant expression was further reduced in mutant AT2 cells, whereas a subset of AT2 
genes, such as Il33 and Lcn2, were increased, suggesting the formation of transcriptionally 
“exaggerated” AT2 cells in the absence of YAP/TAZ (Fig. 24 b, c, and Fig. 25g). Such 
exaggerated differentiation was evident in a Monocle trajectory analysis to capture the 
associated transcriptomic shift, showing ectopic appearance of cells and associated genes, such 
as Il33, beyond the normal AT2 cells in the Y/TSox9 mutant (Fig. 25h, I). This linear trajectory 
was different from the bifurcated one that included SOX9 progenitors (Fig. 23b), suggesting that 
Y/TSox9 mutant cells were not arrested as progenitors, but differentiated toward and even past 
the embryonic AT2 cell fate. The loss of AT1 cell fate was confirmed by immunostaining for 
HOPX and PDPN, consistent with prior Yap/Taz mutant phenotypes (Nantie et al., 2018), while 
most cells in the mutant lung expressed AT2 markers including SFTPC and LAMP3 (Fig. 24 d 
 106 
and e). 
 To relate the transcriptomic shift upon Yap/Taz deletion to the change in NKX2-1 
binding, we assigned the 20% most decreased or increased NKX2-1 sites to their nearest gene 
and derived an average expression score for each gene set and plotted them along the Monocle 
trajectory, as in our temporal analysis (Fig. 23). The resulting module score for the decreased 
sites trended lower toward the exaggerated AT2 cells, suggesting that loss of NKX2-1 binding 
correlated with and likely contributed to gene downregulation (Fig. 25j). Conversely, increased 
NKX2-1 binding upon Yap/Taz deletion likely underlay exaggerated AT2 differentiation (Fig. 
25j). Taken together, as predicted by our motif analysis, YAP/TAZ/TEAD indeed confers AT1-
specific function of NKX2-1 during AT1 cell specification. Formation of exaggerated AT2 cells 
in the Y/TSox9 mutant suggested that resolving AT1 versus AT2 cell fate is a gradual process by 
resisting differentiation toward the opposing cell fate so that, without YAP/TAZ – the “pro-






Fig. 24. Additional analysis of YAP/TAZ as partner factors for NKX2-1 during 
development 
(a) Violin plots of scRNA-seq data from Fig. 4 in color-coded cell types, showing enrichment of 
Tead1/4 and Hippo signaling target genes Ctgf and Cyr61 in AT1 cells and Cebpa/d in AT2 
cells. (b) Feature plots of scRNA-seq comparison of Y/TSox9 mutant and littermate control 
lungs, as in Fig. 25. The left half (bracket; exaggerated AT2 cells) of the AT2 cell cluster in the 
Y/TSox9 mutant loses the low expression of an AT1 gene (Ager) but ectopically expresses Il33 
and Scgb1a1, the latter of which has a low level of expression in control AT2 cells. (c) Volcano 
plot of scRNA-seq data from Fig. 25 comparing AT1 cells in the control lung to AT2 cells in the 
Y/TSox9 mutant, which arise in part from AT1 cells upon Yap/Taz deletion, consistent with 
Yap/Taz mutant AT1 cells becoming AT2 cells. (d, e) Confocal images of immunostained lungs 
showing loss of AT1 markers PDPN and HOPX and wide-spread AT2 markers LAMP3 and 





Fig. 25. AT1-specific partner factors YAP/TAZ establish AT1-specific NKX2-1 binding 
and cell fate, and antagonize those of AT2 cells 
(a) Top enriched HOMER de novo motifs for AT1-specific (TEAD), common (FOXA and 
CTCF), AT2-specific (CEBP) NKX2-1 binding sites. NKX motif (not listed) is most enriched 
for all three groups as expected. (b) Nuclear YAP/TAZ (transcription cofactors of TEADs) and 
CEBPA are specifically detected (arrowhead) in AT1 and AT2 cells, respectively. Since 
YAP/TAZ and CEBPA antibodies are of the same species as the NKX2-1 antibody, AT1 and 
AT2 nuclei are genetically labeled with ShhCre, but distinguishable by LAMP3 and cuboidal 
ECAD staining that are specific for AT2 cells. Scale: 10 µm. (c) Confocal images of 
immunostained E18.5 Yap/TazCKO/CKO; Sox9CreER/+ mutant (abbreviated as Y/TSox9) and 
littermate control lungs with 3 mg tamoxifen (Tam) administered at E15.5, showing loss of 
nuclear YAP/TAZ staining that is otherwise detected in flattened AT1 cells, as outlined by 
ECAD (arrowhead). Scale: 10 µm. (d) NKX2-1 ChIP-seq heatmaps of E18.5 Y/TSox9 mutant 
and littermate control whole lungs, grouped into peaksets with decreased (top) or increased 
(bottom) NKX2-1 binding and sorted by the corresponding fold change, and cross-referenced 
with NKX2-1 binding in purified mature AT1 and AT2 cells from Fig. 1. Decreased NKX2-1 
binding upon Yap/Taz deletion corresponds to more NKX2-1 binding in AT1 cells, whereas 
increased binding corresponds to more binding in AT2 cells. (e) Example NKX2-1 binding sites 
of the decreased (left; Spock2 and Hopx) or increased (right; Lamp3 and Cebpa) category in the 
Y/TSox9 mutant, as in d. NKX2-1 binding for Spock2 and Lamp3 in mature AT1 and AT2 cells 
are shown in Fig. 1. (f) ScRNA-seq UMAP comparison of Y/TSox9 mutant and littermate control 
epithelial cells of indicated cell types and numbers, as supported in the dot plot for their 
respective markers. The decrease in the number of AT1 cells is accompanied by an increase in 
the number of AT2 cells in the mutant. (g) Volcano plots comparing AT1 (left) and AT2 (right) 
cells in Y/TSox9 mutant and littermate control lungs. AT1 cells in the mutant lung are fewer in 
number f and upregulate AT2 genes (purple). AT2 cells in the mutant lung are more abundant f 
and downregulate the low level of AT1 genes (green) that is normally present in E18.5 AT2 
cells, but upregulate some AT2 genes (e.g. Il33) normally expressed in mature AT2 cells. 
Differentially expressed genes in curated lists of AT1 and AT2-specific genes (Supplementary 
Table 6) are labeled (same in subsequent figures).  (h) Monocle trajectory analysis of AT1 and 
AT2 cells in f, showing a linear transcriptomic shift from AT1 to AT2 cells in the control lung 
but further extending to transcriptionally exaggerated AT2 cells (bracket) in the Y/TSox9 mutant, 
as marked by respective markers including Il33. The progenitor marker Sox9 is present at a low 
level but normally higher in AT2 cells. (i) Monocle trajectory heatmap to cluster genes with 
similar dynamics along the transcriptomic shift from AT1 to AT2 and then exaggerated AT2 
cells. (j) Seurat module scores of gene sets associated with the 20% most decreased (top) or 
increased (bottom) NKX2-1 binding sites in d, plotted along the Monocle trajectory in h and 
colored for control and Y/TSox9 mutant lungs, showing concordant changes in NKX2-1 binding 
and gene expression on average. 
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4.2.6 YAP/TAZ maintain AT1-specific NKX2-1 binding and cell fate, and prevent AT1-to-AT2 
conversion  
 In the Y/TSox9 mutant model, both AT1 and AT2 cells were targeted as descendants of 
SOX9 progenitors and NKX2-1 ChIP-seq was performed using whole lungs. To pinpoint the 
role of YAP/TAZ specifically in AT1 cells and to test whether YAP/TAZ continued to function 
as partner factors for NKX2-1 after cell fate specification, we generated Yap/TazCKO/CKO; 
RosaSun1GFP/+; Wnt3aCre/+ mutants (abbreviated as Y/TWnt3a) and performed NKX2-1 ChIP-seq 
using purified AT1 cells from P15 control and Y/TWnt3a mutant lungs (YAP/TAZ lost in 62% of 
2,147 GFP cells from 3 mice; Fig. 27a). Y/TWnt3a mutant AT1 cells had decreased NKX2-1 
binding for AT1-specific sites and intriguingly again, increased binding for AT2-specific sites, 
as respectively exemplified by sites near Spock2 and Scnn1g as well as Lamp3 and Cebpa (Fig. 
27 b and c), suggesting considerable plasticity of AT1 cells such that NKX2-1 relocated to AT2-
specific sites in the absence of YAP/TAZ. 
 ScRNA-seq analysis showed that the Y/TWnt3a mutant had a cluster of AT1 cells that 
were transcriptionally distinct from their normal counterparts that presumably had escaped 
complete Cre recombination (Fig. 27d). Comparison of AT1 cells in the control and mutant 
lungs revealed downregulation of AT1 genes and importantly, upregulation of AT2 genes, 
suggesting possible AT1-to-AT2 conversion (Fig. 26 and Fig. 27e). This possibility was 
supported by a Monocle trajectory analysis that placed mutant AT1 cells between control AT1 
and AT2 cells with intermediate levels of AT1 and AT2 genes (Fig. 27 f and g). Remarkably, 
immunostaining showed that GFP-marked Wnt3aCre lineage cells in the Y/TWnt3a mutant 
expressed AT2 markers including SFTPC and LAMP3 with an increased frequency from P15 
(19% of 1,939 GFP cells from 3 mice) to 10-week-old (56% of 1,833 GFP cells from 2 mice) 
and even became cuboidal as AT2 cells (Fig. 25h), providing genetic evidence for an unusual 
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cell fate conversion of a terminally differentiated cell type. By design, AT2 cells were not 





Fig. 26: Additional analysis of the Y/TWnt3a mutant 
(a) Feature plots of scRNA-seq comparison of Y/TWnt3a mutant and littermate control lungs, as 
in Fig. 27. The right half (bracket; intermediate) of the AT1 cell cluster in the Y/TWnt3a mutant 
ectopically expresses AT2 genes Sftpc and Lamp3, as well as genes implicated in AT2-to-AT1 
conversion during injury-repair such as Sfn. (b) Volcano plot of scRNA-seq data from Fig. 27 
comparing AT2 cells in the control lung to AT1 cells in the Y/TWnt3a mutant to confirm their 
expected cell type identity. 
  
 114 
 As in our analysis of the Y/TSox9 mutant, we assigned the 20% most decreased or 
increased NKX2-1 binding sites in the Y/TWnt3a mutant to their nearest gene and derived an 
average expression score to correlate with the Monocle transcriptomic shift. The observed 
correlation supported the functionality of altered NKX2-1 binding (Fig. 27i). Intriguingly, the 
intermediate cells activated genes that were implicated in AT2-to-AT1 conversion during 
injury-repair, such as Sfn, Krt8, and Lgals3 (Kobayashi, Tata et al., 2020, Strunz, Simon et al., 
2020), suggesting a shared gene signature during cell fate changes (Fig. 26a and Fig. 27 e-g) 
Notably, unsupervised principal component analysis (PCA) of all our NKX2-1 binding datasets 
recapitulated the gradual differentiation of E14.5 progenitors toward the opposing AT1 and AT2 
cell fates; while the E18.5 Y/TSox9 mutant drifted horizontally past AT2 cells, consistent with 
exaggerated AT2 cells, and the P15 Y/TWnt3a mutant AT1 cells drifted toward AT2 cells, 
consistent with AT1-to-AT2 conversion (Fig. 27j). Therefore, NKX2-1 binding over time and 
across mutants mirrored the corresponding transcriptomes (Fig. 21, 23, and 25), supporting the 




Fig. 27. YAP/TAZ maintain AT1-specific NKX2-1 binding and cell fate, and prevent AT1-
to-AT2 conversion 
(a) Confocal images of immunostained lungs showing loss of YAP/TAZ in GFP-expressing 
recombined AT1 cells (filled versus open arrowhead) in the Yap/TazCKO/CKO; Wnt3aCre/+ mutant 
(abbreviated at Y/TWnt3a). Scale: 10 µm. (b) NKX2-1 ChIP-seq heatmaps of purified AT1 nuclei 
from P15 Y/TWnt3a mutant and littermate control lungs, grouped into peaksets with decreased 
(top) or increased (bottom) NKX2-1 binding and sorted by the corresponding fold change, and 
cross-referenced with NKX2-1 binding in purified mature AT1 and AT2 nuclei from Fig. 1. 
Decreased NKX2-1 binding upon Yap/Taz deletion corresponds to more NKX2-1 binding in 
mature AT1 cells, whereas increased binding corresponds to more binding in mature AT2 cells. 
(c) Example NKX2-1 binding sites of the decreased (left; Spock2 and Scnn1g) or increased 
(right; Lamp3 and Cebpa) category in the Y/TWnt3a mutant, as in b. NKX2-1 binding for Spock2 
and Lamp3 in mature AT1 and AT2 cells are shown in Fig. 1. (d) ScRNA-seq UMAP 
comparison of Y/TWnt3a mutant and littermate control epithelial cells of indicated cell types and 
numbers, as supported in the dot plot for their respective markers. AT1 cells in the mutant form 
two clusters, likely reflecting Yap/Taz mutant AT1 cells and those that have not undergone 
complete recombination, respectively. The higher AT1 cell number in the mutant possibly 
results from a higher efficiency in cell dissociation due to the change in cell morphology as part 
of the mutant phenotype, as demonstrated in h. (e) Volcano plots comparing AT1 (left) and AT2 
(right) cells in Y/TWnt3a mutant and littermate control lungs. AT1 cells in the mutant lung 
downregulate AT1 genes (green) and upregulate AT2 genes (purple), as well as genes 
associated with AT2-to-AT1 conversion during injury-repair (grey)(Kobayashi et al., 2020, 
Strunz et al., 2020). AT2 cells in the mutant lung do not have changes in cell type-specific genes 
since Wnt3aCre is an AT1-specific driver. (f) Monocle trajectory analysis of AT1 and AT2 cells 
in d, showing a linear transcriptomic shift from AT1 to AT2 cells in the control lung but via 
intermediate cells (bracket) in the Y/TWnt3a mutant, which express a subset of AT1 (Spock2) and 
AT2 (Sftpc) genes as well as Sfn.  (g) Monocle trajectory heatmap to cluster genes with similar 
dynamics along the transcriptomic shift from AT1 to intermediate and then AT2 cells. (h) 
Confocal images of immunostained lungs showing expression of AT2 markers (LAMP3 and 
SFTPC) in GFP-expressing Wnt3aCre-lineage cells in the Y/TWnt3a mutant (filled versus open 
arrowhead). Some SFTPC-expressing mutant cells still have extended morphology at P15 (open 
arrow), and become mostly cuboidal at 10 weeks. Scale: 10 µm. (i) Seurat module scores of 
gene sets associated with the 20% most decreased (left) or increased (right) NKX2-1 binding 
sites in b, plotted along the Monocle trajectory in f and colored for control and Y/TWnt3a mutant 
lungs, showing concordant changes in NKX2-1 binding and gene expression on average. (j) 
Unsupervised principal component analysis of NKX2-1 binding across indicated color-coded 
samples. Note that the E18.5 Y/TSox9 mutant is right-shifted as far as mature AT2 cells, whereas 
the P15 Y/TWnt3a mutant is between AT1 and AT2 cells, reflecting the exaggerated AT2 cells 
and intermediate cells in the respective mutants. (k) A diagram, reminiscent of and color-coded 
as in j, depicting the normal differentiation of progenitors toward AT1 and AT2 cells, as well as 
the drift in both NKX2-1 binding and transcriptome observed in Y/TSox9 and Y/TWnt3a mutants. 
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4.2.7 Cell type-specific Nkx2-1 mutant cells explore distinct epigenetic space including the 
opposing cell fate 
 The increased NKX2-1 binding to AT2-specific sites in both Yap/Taz mutants and 
associated shift of cells towards AT2 cell fate, together with the known AT2-to-AT1 
differentiation during injury-repair (Barkauskas et al., 2013, Desai et al., 2014), raised the 
possibility of a constant antagonism between the opposing AT1 versus AT2 cell fate. If true, we 
reasoned that loss of one cell fate in our NKX2-1Rtkn2 and NKX2-1Sftpc mutants might permit the 
opposing cell fate. Accordingly, we focused on sites with increased chromatin accessibility 
upon Nkx2-1 deletion and found that those in the two Nkx2-1 mutants had little overlap (445 
sites shared between 18,367 and 11,275 sites) (Fig. 28a), suggesting that Nkx2-1 mutant AT1 





Fig. 28. Cell type-specific Nkx2-1 mutant cells explore distinct epigenetic space including 
the opposing cell fate 
(a) ATAC-seq heatmaps of sites with increased chromatin accessibility in purified AT1 (top) 
and AT2 (bottom) cells from the respective NKX2-1Rtkn2 and NKX2-1Sftpc mutants as in Fig. 20, 
cross-compared with and sorted by NKX2-1 binding in 10-week-old AT1 versus AT2 cells from 
Fig. 1. The sites from the two mutants have limited overlap and are largely not bound by NKX2-
1, although 10% sites (boxed area) have NKX2-1 binding (arrowhead) and corresponding 
increased chromatin accessibility (log2 fold change shown) in control cells of the opposing fate. 
(b) Top enriched HOMER de novo motifs for sites in a as well as their p values and percentage 
of sites containing the predict motif. Note limited overlap except for the AP-1 motif and CEBP 
and TEAD motifs in the opposing cell types. (c) MA plots of genes associated with the boxed 
10% sites in a using published bulk RNA-seq data of AT1-specific and AT2-specific Nkx2-1 
mutant developing lungs(Little et al., 2019), showing that increased chromatin accessibility of 
sites of the opposing cell fate does not correspond to gene upregulation. (d) Example increased 
chromatin accessibility in sites near a gastrointestinal gene (Hnf4a; distinct sites for NKX2-
1Rtkn2 versus NKX2-1Sftpc mutants), AT2-specific NKX2-1 sites (Lyz2) in the NKX2-1Rtkn2 
mutant, and an AT1-specific NKX2-1 site (Pdpn) in the NKX2-1Sftpc mutant. The decreased 
chromatin accessibility of Lyz2 and Pdpn sites in the concordant mutant is examined in Fig. 20. 
(e) A diagram to depict that NKX2-1 promotes the differentiation of progenitors toward AT1 or 
AT2 fate possibly in partner with YAP/TAZ/TEAD or CEBPA, respectively. Without NKX2-1, 
















 In support of this, motif analysis of newly accessible sites in the NKX2-1Rtkn2 and 
NKX2-1Sftpc mutants revealed mostly unique motifs, except for the AP-1 motif that was shared 
in both mutants, perhaps reflecting a common stress response to cell cycle reentry or cell fate 
change (Wisdom, 1999) (Fig. 28b). Loss of NKX2-1 in either AT1 or AT2 cells were known to 
adopt a gastrointestinal fate during development, homeostasis, and tumorigenesis (Little et al., 
2019, Maeda et al., 2012, Snyder et al., 2013, Tata et al., 2018, Winslow et al., 2011); however, 
gastrointestinal genes shared between mutant AT1 and AT2 cells, such as Tff2 (Little et al., 
2019, Tata et al., 2018), had gained little chromatin accessibility 5 days after Nkx2-1 deletion 
(Fig. 29a). There is evidence that FOXA1/A2 are released from NKX2-1 to activate a key 
gastrointestinal transcription factor Hnf4a (Snyder et al., 2013, Winslow et al., 2011); however, 
the FOXA motif was limited to the NKX2-1Sftpc mutant and Hnf4a had gained chromatin 
accessibility in both mutants but at distinct sites (Fig. 28d), suggesting other mechanisms to 
activate gastrointestinal genes in the NKX2-1Rtkn2 mutant (Fig. 28b). Interestingly, Elf3 of the 
ELF motif family, a transcription factor required for gastrointestinal development (Ng, Waring 
et al., 2002), was ectopically expressed in Nkx2-1 mutant AT1 cells (Fig. 29 b and c). 
 Intriguingly, one pair of motifs for the newly accessible sites were for the opposing cell 
fate: CEBP motif for the NKX2-1Rtkn2 mutant and TEAD for the NKX2-1Sftpc mutant (Fig. 7b). 
When cross-referencing chromatin accessibility with NKX2-1 binding, we found that most 
increased sites were not associated with NKX2-1 binding, consistent with these sites being 
indirect targets of NKX2-1 (Fig. 29a) (Little et al., 2019). However, 10-15% of the sites had 
NKX2-1 binding albeit in the opposing cell type, and were more accessible in the opposing cell 
type of control lungs (Fig. 29a), suggesting increased chromatin accessibility in some AT2-
specific genes in the NKX2-1Rtkn2 mutant and some AT1-specific genes in the NKX2-1Sftpc 
mutant, as respectively exemplified by Lyz2 and Pdpn (Fig. 29d). Despite increased chromatin 
accessibility, these genes were mostly not upregulated transcriptionally in previously published 
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mutants (Little et al., 2019) (Fig. 29c), suggesting that while Nkx2-1 mutant AT1 and AT2 cells 
may explore epigenetic accessibility of the opposing cell fate, the new chromatin accessibility 
does not translate into gene expression, presumably due to the absence of NKX2-1. Taken 
together, the limited overlap between newly accessible sites and enriched motifs between the 
two Nkx2-1 mutants suggested that mutant AT1 and AT2 cells converge onto the 
gastrointestinal fate by following non-linear and distinct epigenetic paths including those toward 

























Fig. 29. Additional analysis of increased chromatin accessibility sites in the Nkx2-1 
mutants 
(a) Example gastrointestinal genes (Tff1/2/3) with little increase in chromatin accessibility 
except for a small change near Tff2 in the NKX2-1Sftpc mutant (asterisk), possibly due to faster 
adoption of the gastrointestinal fate by AT2 cells than AT1 cells. (b) ScRNA-seq UMAPs of our 
published NKX2-1Aqp5 mutant showing the indicated cell types and numbers. (c) Violin plots of 
the scRNA-seq data in b, showing increased expression of gastrointestinal genes including 





 Our native tissue-derived genomic data has delineated the in vivo function of the lung 
lineage transcription factor NKX2-1 in opposing cell types and across developmental stages. 
Key unexpected findings include (1) cell type-specific NKX2-1 binding is preferentially 
acquired and retained as progenitors differentiate into each cell type, supporting the concept of 
cell fate and potential marked by NKX2-1 binding; (2) the AT1 and AT2 cell fates continuously 
antagonize each other so that YAP/TAZ and by extension TEADs function as partner factors of 
NKX2-1 in AT1 cells, restricting NKX2-1 binding to AT1-specific sites and preventing cell fate 
conversion in a development stage-dependent manner; (3) loss of NKX2-1 allows AT1 and AT2 
cells to gain cell type-specific chromatin accessibility associated with the alternative cell fate 
without corresponding transcriptional activation, suggesting that a lineage transcription factor 
can be coerced in one cell type to inhibit the epigenetic state of the opposing cell type. Our cell 
type-specific epigenomic and genetic study sheds light on the molecular logic of resolving 
opposing cell fates by a lineage transcription factor in native tissues.  
 Lineage transcription factors including NKX2-1 mark a given tissue lineage and by 
definition, are expressed among each cell type within the lineage. However, on the protein level, 
they could theoretically have cell type-specific post-translational modifications, DNA-binding 
targets, or binding partners – possibilities that are discernible only by comparing pure cell type 
populations and practically often addressed in cultured cells (Adam et al., 2018, Spitz & 
Furlong, 2012, Trompouki et al., 2011). The abundance of AT1 and AT2 cells and their robust 
genetic drivers allow us to identify shared and distinct NKX2-1 binding sites and test the 
functionality of such binding in native tissues. We show that cell type-specific NKX2-1 binding 
sites, compared to common ones, are more often associated with distal regulatory elements and 
are functional in regulating chromatin accessibility, extending such general transcriptional 
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mechanisms (Spitz & Furlong, 2012) to opposing cell types of the same lineage in vivo. 
Integrating scATAC-seq data that can now be readily obtained for native tissues, we parse the 
aforementioned common NKX2-1 binding sites into lineage and housekeeping ones, the former 
of which lose chromatin accessibility upon Nkx2-1 deletion (Fig. 18 and 20), supporting a 
shared function of NKX2-1 in AT1, AT2 and possibly airway cells. By comparison, NKX2-1 
binding to housekeeping sites including possible insulators implies its more general role in 
chromatin organization, although site chromatin accessibility is largely unaffected without 
NKX2-1, possibly due to redundancy with other transcription factors expected at these generic 
sites. Future 3D chromatin analysis (Kantidze & Razin, 2020) and extension of our approaches 
to airway cell types as well as other tissues will provide a complete picture of how lineage 
transcription factors function in vivo. 
 Cell type-specific NKX2-1 binding cannot be explained by the bound DNA sequences 
alone as they are identical in AT1 and AT2 cells. Nevertheless, motif analysis of the NKX2-1- 
bound sequences in AT1 versus AT2 cells identifies the expected shared NKX motif, as well as 
AT1-specific TEAD motif and AT2-specific CEBP motif, consistent with binding specificity as 
a result of partner transcription factors. Indeed, AT1-specific NKX2-1 binding depends on 
YAP/TAZ, cofactors of TEADs (Fig. 25, 27) – prompting future investigation of the role of 
CEBPs in AT2-specific NKX2-1 binding beyond existing phenotypic characterization (Martis, 
Whitsett et al., 2006), as well as equivalent partner factors in NKX2-1-expressing airway cells 
or in the context of injury-repair or tumorigenesis using more sensitive variants of ChIP-seq 
(Meers, Bryson et al., 2019). Activatable by cell stretching (Zheng & Pan, 2019) possibly from 
lung growth and/or inspiration, YAP/TAZ could recruit NKX2-1 to promote AT1 cell growth, 
which in turn releases tension and prevents additional cells from adopting the AT1 cell fate – a 
negative feedback mechanism to generate a mosaic of AT1 and AT2 cells that is distinct from 
Notch-mediated lateral inhibition and possibly allows continuous antagonism between AT1 and 
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AT2 cell fates. In support of this, loss of YAP/TAZ shifts NKX2-1 to its AT2-specific sites, 
eventually leading to AT2 gene expression and morphology (Fig. 27). 
 The conversion among AT1, AT2, and gastrointestinal fates in this study and the 
literature highlights remarkable cellular plasticity, even for a terminally differentiated cell type 
such as the AT1 cell(Barkauskas et al., 2013, Desai et al., 2014, Jain et al., 2015, Little et al., 
2019, Maeda et al., 2012, Tata et al., 2018, Wang et al., 2018, Winslow et al., 2011, Yang et al., 
2016). The theoretical potential of a cell is only limited by its DNA sequence, as demonstrated 
in the extreme case of inducing pluripotent stem cells from fibroblasts ((Takahashi & 
Yamanaka, 2006). However, during normal development and homeostasis, the physiological 
potential of a cell is much more limited, as conceptualized in the Waddington landscape model 
(Waddington, 1957) –testable with lineage-tracing and transplant experiments – and 
exemplified, in this study, by the potential of SOX9 progenitors to form both AT1 and AT2 
cells. We show that at least one underlying mechanism is NKX2-1 binding to retained sites, 
marking them for future expression (Fig. 21 and 23). More often, the literature illustrates the 
experimental potential of a cell, where loss or gain-of-function manipulations alter a cell fate. 
Loss-of-function settings often reveal a potential based on ongoing antagonism or shared 
developmental origin, as exemplified in the AT1-AT2 balance or the endodermal origin of the 
lung and the gut, respectively, and demonstrated in our Yap/Taz and Nkx2-1 mutants (Fig. 25, 
27, and 28). Gain-of-function settings including directed differentiation are widely used in 
regenerative medicine but often do not fully recapitulate the intended cell fate (Firas, Liu et al., 
2015), possibly due to the ability of cells to explore a larger epigenetic space (Fig. 28) in 
addition to the difficulty in precisely controlling the level and duration of the overexpression. 
Systematic comparison of the epigenome and transcriptome underlying the theoretical, 
physiological, and experimental potentials will supplement ongoing efforts in cataloging all cell 
types in the body (Ponting, 2019). 
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Chapter 5: Discussion and Future Directions 
 
5.1 Conclusions 
 Throughout my dissertation, I set up an in vivo paradigm to dissect the function of 
lineage specific transcription factors across the alveolar epithelial cell types of the lung. As a 
result, I identified NKX2-1 as first transcription factor necessary for the AT1 cell specification, 
development, and maintenance, and determined that it is also required for chromatin 
accessibility at AT1-specific binding sites established through cooperation with cell type-
specific transcription co-factors YAP/TAZ. Leveraging developmental time points, cell types, 
and chromatin accessibility across lineages, we discovered that genome-wide binding of the 
lineage transcription factor NKX2-1 drives cellular identity through positive regulation of cell 
type and lineage-specific DNA regulatory elements. Interestingly, in addition to positive 
reinforcement of AT1 and AT2 cell fate, NKX2-1 inhibits phenotypic conversion of AT1 and 
AT2 cells into gastrointestinal cells, and chromatin accessibility at the alternative alveolar fate’s 
cell type-specific NKX2-1 binding.  
 This study demonstrates that lineage specific transcription factors in vivo bind to 
housekeeping DNA regulatory elements shared between lung tissue lineages including possible 
insulators along with sites specific to the lung epithelial lineage and distinct lung epithelial cell 
types. Through such binding and regulation of chromatin accessibility in a cell type-specific 
manner, lineage transcription factors maintain lineage fidelity and terminal cellular identity 
through binding guided by cell type-specific activated transcription co-factors. Leveraging the 
alveolar epithelium with two distinct cell types descending from a common progenitor, we 
carried out a genome-wide in vivo analysis of a lineage transcription factor’s binding in each 
cell type. From such analyses and differential comparison between the two cell types, we 
observed that lineage transcription factors establish cell type-specific binding guided by cell 
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type-specific transcription co-factors to newly bound sites during cellular differentiation and 
also retain binding sites from the progenitor. Unlike in AT1 or AT2 cells, these retained NKX2-
1 binding sites for both cell types were not associated with active gene expression in the 
progenitor, suggesting that lineage transcription factors may also play a role in the 
developmental potential of a cell in vivo. Thus, our investigation not only lays the foundation to 
further delineate the role of lineage transcription factors in binary cell fate decision, but also 
provides an excellent model to examine the role of lineage transcription factors in cellular 
plasticity.  
In addition to expanding our knowledge of lineage transcription factors in vivo, we have 
advanced our understanding of AT1 and AT2 cell identity and development an in-depth 
epigenomic analyses of the alveolar epithelium. With emphasis on the AT1 cell, we highlight 
the cellular plasticity of the otherwise terminally differentiated cell type, demonstrating that the 
AT1 cell is capable of proliferation, as well as conversion to a gastrointestinal and AT2 cell 
fates both through gene expression and physical transformation. Furthermore, it builds upon 
recent investigations into the requirement of mechanical tension and HIPPO responsive 
transcription co-factors YAP/TAZ in AT1 specification, demonstrating that YAP/TAZ are 
required during AT1 cell maturation and repression of AT2 cell identity. This lends credence to 
previous findings in the lung field suggesting that AT1 cells possess the capacity to differentiate 
into AT2 cells upon wide-spread lung injury. Together, with the aforementioned proliferation 
and transformation into a gastrointestinal cell fate similar to the Nkx2-1 mutant AT2 cells, these 
findings call into question whether AT1 cells are indeed passive structural components in the 
lung or if they are dynamically involved in lung disease, injury, and regeneration. 
 
5.2 Future Directions 
5.2.1 AT1 cells as an active structural component in the lung 
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The combination of the technical difficulties associated with imaging, culturing, and 
recovering AT1 cells for scRNA-seq using traditional epithelial sorting antibodies in the lung 
field such as EPCAM have resulted in the lack of knowledge surrounding the AT1 cell in the 
context of lung disease and injury (Cain et al., 2020, Weibel, 1971). Our findings suggest that 
AT1 cells are plastic, undergoing a gastrointestinal transformation similar to that of AT2 cells 
upon loss of Nkx2-1, and conversion to AT2 cell fate in the absence of Yap/Taz. This 
gastrointestinal lineage switch and wide-spread proliferation in the Nkx2-1 mutant AT1 cells 
supports two previous findings that with the lung adenocarcinoma mouse model KrasLSL-G12D 
and ectopic Sox2 expression, a subset of AT1 cells possess tumorigenic capacity (Jain et al., 
2015, Yang et al., 2016).  Between our AT1 and AT2 Nkx2-1 mutants we observed differences 
in the kinetics by which cells adopted a gastrointestinal fate, the gastrointestinal genes 
expressed, and the transcription factors motifs associated with newly accessible sites identified 
by ATAC-seq. While a subset of AT1 cells may only possess the capacity to form tumors as 
observed in the KrasLSL-G12D lung adenocarcinoma model (Jain et al., 2015), further investigation 
is merited to determine if differences exist between tumors originating from AT1 or AT2 cells 
that could be exploited to therapeutically benefit patients.  
Only recently, AT1 cells have been studied in the context of lung injury and repair. 
While conversion of AT1 to AT2 cells was observed, the data was limited to the 
pneumonectomy model of lung injury and in vitro cell culture experiments (Jain et al., 2015). 
These findings were refined by the identification of two AT1 cell populations, one considered 
mature that was shown to not transform into AT2 cells in the same injury model and in vitro, 
and nascent AT1 cells that possessed conversion potential (Wang et al., 2018). Thus, it is 
possible that our observations of AT1 to AT2 conversion in developing AT1 cells is limited to 
immature AT1 cells. To test this possibility, deletion of Yap/Taz should be carried out in mature 
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AT1 cells. Furthermore, lineage tracing of AT1 cells in different injury models is necessary to 
determine a common role of AT1 cells in response to lung injury.  
 
5.2.2 Lung development  
This study examines NKX2-1 binding in the AT1 cell and suggests that it requires the 
TEAD co-transcription factors YAP/TAZ to bind at AT1-specific sites. However, the question 
of if TEAD family members bind within AT1-specific NKX2-1 bound sites remains, prompting 
future experiments to resolve if TEADs interact with NKX2-1 to determine AT1 cell identity. In 
addition to TEADs, there are other motifs present at a subset of AT1-specific NKX2-1 binding 
sites that share cell type-specific gene expression which could contribute to a smaller portion of 
AT1-specific sites. This draws into question the complexity underlying AT1 cell fate, and if 
different elements of AT1 cell fate and NKX2-1 binding are driven by clusters of transcription 
factors. While we focused on the murine lung, advances in single-cell technology have enabled 
us to cross-compare our findings with human samples. Recent human scRNA-seq data of the 
lung also confirms expression of Nkx2-1 and expression of canonical TEAD targets Ctgf and 
Cyr61 in AT1 cells (Zheng & Pan, 2019), raising the possibility that our findings may be 
preserved in the human lung (Travaglini, 2020). This prospect gives further merit to investigate 
of how TEAD and NKX2-1 cooperate to form and maintain AT1 cell identity, and if additional 
transcription factors are also necessary for the differentiation of AT1 cells.  
While our study focuses on NKX2-1 regulation of AT1 cell identity, it also identifies the 
cell type-specific transcription factor CEBPA as a candidate transcription factor to guide 
NKX2-1 binding in the AT2 cell. However, deletion of Cebpa in the developing murine embryo 
leads to branching defects in addition to AT1 and AT2 differentiation defects (Martis et al., 
2006). As mentioned in Chapter 1, such branching defects can influence alveolar specification 
and thus confound our interpretations of Cebpa function in alveolar differentiation. To 
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circumvent these branching defects, a spatiotemporally controlled mosaic deletion of Cebpa in 
SOX9 progenitors could determine if both cell types are affected or if AT2 cells solely require it 
for specification. The role of Cebpa should also be assessed in AT2 cells of the mature lung, and 
if it regulates NKX2-1 AT2-specific binding, preventing binding to AT1-specific sites. Carrying 
out such experiments, would significantly improve our understanding of AT2 development and 
maintenance, and determine if NKX2-1 cell type-specific binding is predominantly guided by 
cell type-specific transcription factors in both AT1 and AT2 cells.  
Although we provide a view of lung epigenetics from the perspective of NKX2-1, our 
research is one of the first in-depth in vivo epigenetics studies in the alveolar epithelium. It 
curated cell type-specific data that can be applied to different contexts including development 
and disease. Extensive profiling of the histone modifications H3K4me3, H3K27ac, and 
H3K4me1 for AT1 and AT2 cells opens the door for other comparative analyses to advance the 
field of lung development. For instance, analysis of the H3K27ac epigenetic modification can be 
used to identify dense clusters of active enhancers known as super-enhancers that control genes 
essential to cell identity (Adam & Fuchs, 2016, Shin, 2018). Super-enhancers are particularly 
important for cell type specification and expression of developmentally regulated genes (Adam 
& Fuchs, 2016, Shin, 2018). Upon their identification in the AT1 and AT2 cells, putative super-
enhancers can be cross compared for chromatin accessibility across all cell types of the lung to 
increase confidence in their cell-type specific activity and be experimentally tested by 
generating CRISPR knockouts of candidate regulatory elements near AT1 or AT2 cell type-
specific genes. This would further our understanding of AT1 and AT2 cell development and 
epigenomes, and if correlated with NKX2-1 binding it could possibly re-contextualize the role 
of NKX2-1 in development.  
 
  5.2.3 NKX2-1 and lineage transcription factors   
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 Many of the NKX2-1 bound, shared regulatory elements between AT1 and AT2 cells 
had chromatin accessibility across cell types. However, a subset of shared regulatory elements 
were specific to the epithelial lineage with chromatin accessibility in both AT1 and AT2 cells 
and a range of chromatin accessibility within airway cell types. This gives rise to two questions, 
(1) whether Nkx2-1 has a common function shared between all cell types of the lung epithelium 
that is different from housekeeping element regulation, and (2) what drives NKX2-1 binding to 
the DNA regulatory elements specific to the alveolar epithelium. Lineage-specific NKX2-1 sites 
sharing chromatin accessibility with airway cells raises the possibility that NKX2-1 may have 
common binding sites regardless of the terminal cell type identity. Due to the extremely low 
presence of ionocytes, neuroendocrine, and goblet cells, comparison of the epigenomes and 
NKX2-1 binding amongst these rare cell types may not be feasible. However, sufficient cell 
number could be achieved to carry out the new, low-abundance ChIP-seq method Cut and Run 
to ascertain NKX2-1 binding profiles within secretory, ciliated and possibly basal cells (Meers 
et al., 2019). This comparison across the airway and alveolar epithelial lineage compartments 
would complement our current study by defining how lineage transcription factors control the 
lineage level of identity, and enable future comparisons to determine if they require other 
transcription factors to establish lineage-specific binding.  
Comparison of NKX2-1 binding within the alveolar epithelium to SOX9 progenitors 
revealed that lineage transcription factors can bind to regulatory elements in progenitors that are 
associated with gene expression specific to their progeny. To confirm this idea, our findings 
should be complemented with analysis of histone modification unbiased by gene annotation in 
the SOX9 progenitor cells to determine whether such regulatory elements are indeed poised for 
activation. If NKX2-1 is associated with poised regulatory elements, this would suggest a 
possible role of lineage transcription factors in regulating cellular potential. In our established 
tractable system, this aspect of lineage transcription factor function could be further investigated 
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in the context of the AT2 cells, which are known to possess the potential to differentiate into 
AT1 cells for both homeostatic turn-over and lung injury. Thus, investigation of NKX2-1 
binding at lineage-specific sites between AT1 and AT2 cells, in combination with asymmetric 
histone activation marks, would serve as a natural next step to uncover lineage transcription 
factor roles in cellular potential.  
 This experimental paradigm one serves as one example of how lineage transcription 
factors bind genome-wide in vivo to orchestrate cell fate during binary cell fate decision. Thus, 
the underlying concepts should be compared and expanded upon in other contexts. In 
comparison with lineage transcription factors functions investigated at individual loci in 
Drosophila, C. elegans, and vertebrate cell lines, NKX2-1 binding genome-wide replicates 
observations that lineate transcription factors are co-opted by terminal cell type-specific 
transcription factors to bind at cell type specific genes (Allan & Thor, 2015, Bertrand & Hobert, 
2010, Jukam & Desplan, 2010). In a genome-wide in vitro study, a lineage transcription factor 
for melanotropes and corticotropes in the pituitary, TPIT, is also seemingly directed by terminal 
cell type-specific transcription factors (Liu, Lin et al., 2001, Mayran, Sochodolsky et al., 2019). 
Furthermore, our observation that lineage transcription factors bind and are required for 
chromatin accessibility at lineage and cell type-specific sites is comparable to the presence of 
TPIT motifs at both POMC lineage-specific accessible sites and melanotrope-specific accessible 
sites and requirement of Tpit for chromatin accessibility (Mayran et al., 2019). While our 
genome-wide in vivo observations are consistent with the limited examples in the literature, 
there are possible variations within lineage transcription factor functions that are not 
encompassed by our in vivo paradigm. Furthermore, our novel binding kinetics analysis and 
comparison is hindered by the staggered waves of development by SOX9 progenitors and 
should be recapitulated in a model with homogenous differentiation of cell types (Alanis et al., 
2014). Thus, while our analyses demonstrate the underlying principles of lineage transcription 
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factors in vivo, similar studies within different organ lineages are necessary to confirm that 
these are standard properties extending to most lineage transcription factors.  
 
  5.2.3 Cell identity and beyond   
 
 This investigation of cellular identity within the alveolar epithelium demonstrates how 
both positive and negative aspects of cellular identity described in Chapter 1 are maintained. 
Specifically, the TEAD co-transcriptional activators Yap/Taz are necessary for positive 
reinforcement of AT1 cell identity and repression of AT2 cell identity. This example further 
strengthens similar observations of cell fate switches seen in many neuronal contexts (Arlotta & 
Hobert, 2015).  However, the lineage transcription factor NKX2-1 is required for positive 
maintenance of lineage level of identity and cell type-specific identity, suppressing a wide-
spread lineage switch to gastrointestinal cell fate and to a smaller extent, an epigenetic cell type 
switch within the alveolar epithelium. The lineage switch of lung to gastrointestinal fate is 
consistent with previous examples of region switching in the brain discussed in Chapter 1, but 
the gain of chromatin accessibility at alternate cell type-specific sites in the alveolar epithelium 
upon loss of Nkx2-1 is surprising. Even more surprising is that reciprocal cell type-specific 
transcription factor motifs are observed, suggesting that NKX2-1 serves to positively maintain 
lineage and cell type identity while preventing the interconversion of epigenetic identity within 
the lineage and between tissue lineages. This indicates that phenotypic outputs of cellular 
identity may be insufficient to encapsulate such transformations and further investigation is 
necessary to understand epigenetic vs gene expression changes in the Nkx2-1 mutants.  
 NKX2-1 binding in whole lung tissue identified broad strokes of NKX2-1 function, 
suggesting that both AT1 and AT2 genes were bound, while gastrointestinal genes were not. 
However, use of cell type-specific ChIP-seq demonstrated that it binds differentially between 
the two cell types. Furthermore, by comparing chromatin accessibility across 13 cell types at 
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NKX2-1 binding sites we were able to separate lineage-specific sites from housekeeping sites. 
While this comparative approach was previously limited by technology with the need for 
millions of cells to carry out ChIP-seq, Cut and Run allows analysis of transcription factor 
binding and histone modifications to be carried out on a low abundance cell types. Thus, Cut 
and Run in combination with single-cell technology for ATAC-seq and DNA methylation, 
enable different cell types in vivo to be leveraged similar to time points, genetic manipulations 
and other experimental conditions to understand how the same DNA blueprint is utilized in 
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